image_name stringlengths 68 68 | type stringclasses 2
values | gt_table stringlengths 116 12.6k | table_fragment_1 stringlengths 43 8.42k | table_fragment_2 stringlengths 39 8.21k |
|---|---|---|---|---|
c39756d214ebcd8f0927a400b0232a162e46aeeea90fdbc289db41678192fa6f.png | complex | <table><tr><td>Bacteria</td><td>Aligner</td><td>Bracket</td><td><i>P</i></td></tr><tr><td></td><td><i>n</i>/<i>N</i> (%)</td><td><i>n</i>/<i>N</i> (%)</td><td></td></tr><tr><td colspan="4"><i>S</i>. <i>mutans</i></td></tr><tr><td> Present T0</td><td>13/15 (87%)</td><td>14/15 (93%)</td><td>1.00</td></tr><tr><td> Present... | <table><tr><td>Bacteria</td><td>Aligner</td><td>Bracket</td><td>P</td></tr><tr><td></td><td>n/N (%)</td><td>n/N (%)</td><td></td></tr><tr><td colspan="4">S. mutans</td></tr><tr><td>Present T0</td><td>13/15 (87%)</td><td>14/15 (93%)</td><td>1.00</td></tr><tr><td>Present T1</td><td>12/15 (80%)</td><td>12/15 (80%)</td><td... | <table><tr><td>Bacteria</td><td>Aligner</td><td>Bracket</td><td>P</td></tr><tr><td></td><td>n/N (%)</td><td>n/N (%)</td><td></td></tr><tr><td colspan="4">S. sanguinis</td></tr><tr><td>Present T0</td><td>15/15 (100%)</td><td>15/15 (100%)</td><td>NC</td></tr><tr><td>Present T1</td><td>15/15 (100%)</td><td>15/15 (100%)</t... |
1b530d12f0003b38d5cdd711722e711e25a3c433099b9c5342ac1b89e5992115.png | complex | <table><tr><td colspan="8">Average percent nucleotide identity (APNI)</td></tr><tr><td><i>Lactobacillus plantarum</i> strains</td><td>WJL</td><td>WCFS1</td><td>ST-III</td><td>P-8</td><td>NC8</td><td>IPLA88</td><td><i>plantarum</i><sup>F</sup></td></tr><tr><td>ZJ316</td><td>98.8</td><td>98.9</td><td>98.9</td><td>99.1</t... | <table><tr><td colspan="2">Average percent nucleotide identity (APNI)</td></tr><tr><td>Lactobacillus plantarum strains</td><td>WJL</td></tr><tr><td>ZJ316</td><td>98.8</td></tr><tr><td>plantarumF</td><td>99.3</td></tr><tr><td>IPLA88</td><td>99.1</td></tr><tr><td>NC8</td><td>99.2</td></tr><tr><td>P-8</td><td>98.7</td></t... | <table><tr><td colspan="6">Average percent nucleotide identity (APNI)</td></tr><tr><td>WCFS1</td><td>ST-III</td><td>P-8</td><td>NC8</td><td>IPLA88</td><td>plantarumF</td></tr><tr><td>98.9</td><td>98.9</td><td>99.1</td><td>98.9</td><td>99.2</td><td>98.9</td></tr><tr><td>99.1</td><td>99.3</td><td>98.9</td><td>99.9</td><t... |
29e25f2a8043ff62073573f12b7c576bae154d99e03e1829ea9839774c0087f1.png | complex | <table><tr><td>Name gene</td><td>Oligo direct</td><td>Oligo reverse</td><td>PCR conditions</td><td>Cycle number</td><td>GeneInfo identifier</td></tr><tr><td rowspan="2"><i>18S</i></td><td rowspan="2">CTACCACATCCAAGGAAGGCA</td><td rowspan="2">TTTTTCGTCACTACCTCCCCG</td><td>95°C 15 sec</td><td rowspan="2">35</td><td ... | <table><tr><td>Name gene</td><td>Oligo direct</td><td>Oligo reverse</td></tr><tr><td rowspan="2">18S</td><td rowspan="2">CTACCACATCCAAGGAAGGCA</td><td rowspan="2">TTTTTCGTCACTACCTCCCCG</td></tr><tr></tr><tr><td rowspan="2">ERK1</td><td rowspan="2">CTAAAGCCCTCCAACCTGCT</td><td rowspan="2">CAGCCCACAGACCAGATGT</td></tr><t... | <table><tr><td>PCR conditions</td><td>Cycle number</td><td>GeneInfo identifier</td></tr><tr><td>95°C 15 sec</td><td rowspan="2">35</td><td rowspan="2">124517659</td></tr><tr><td>67°C 30 sec</td></tr><tr><td>95°C 15 sec</td><td rowspan="2">45</td><td rowspan="2">158138506</td></tr><tr><td>60°C 30 sec</td></tr><tr><td>95... |
a515c61f7b365c22af02c47d37e6c920de5b4c61caf4beb09a10716cbbc4881e.png | complex | <table><tr><td>Region</td><td><i>x</i></td><td><i>y</i></td><td><i>z</i></td><td><i>t</i><sub>peak</sub></td><td colspan="2"><i>p</i><sub>corr</sub>(<i>p</i><sub>uncorr</sub>)</td></tr><tr><td colspan="7">TEMPORALLY STABLE EFFECTS: POST-REAL rTMS > POST-SHAM rTMS</td></tr><tr><td colspan="7">Haptic S2—crossmod... | <table><tr><td>Region</td><td>x</td><td>y</td><td>z</td><td>tpeak</td><td colspan="2">pcorr(puncorr)</td></tr><tr><td colspan="7">TEMPORALLY STABLE EFFECTS: POST-REAL rTMS > POST-SHAM rTMS</td></tr><tr><td colspan="7">Haptic S2—crossmodal: VHi</td></tr><tr><td colspan="7">No significant results</td></tr><tr><td colspan... | <table><tr><td colspan="7">No significant results</td></tr><tr><td colspan="7">Visual S2—crossmodal: VHi × time</td></tr><tr><td colspan="7">No significant results</td></tr><tr><td colspan="7">Visual S2—unimodal: VVi × time</td></tr><tr><td colspan="7">No significant results</td></tr></table> |
cd5eb61306665787b5e325f6f43a1017fd3f4cbdbc7bb82ea63c6aad65229b61.png | simple | <table><tr><td>Probe</td><td><i>BRCA1/2</i>-N, median % (range)</td><td>Non-<i>BRCA</i>-related-N, median % (range)</td><td>Test statistic<sup>a</sup></td><td><i>p</i> Value</td></tr><tr><td>BRCA1.1</td><td>2 (0–3)</td><td>3 (0–5)</td><td>15.500</td><td>0.325</td></tr><tr><td>BRCA1.2</td><td>17 (13–26... | <table><tr><td>Probe</td><td>BRCA1/2-N, median % (range)</td><td>Non-BRCA-related-N, median % (range)</td><td>Test statistica</td><td>p Value</td></tr><tr><td>BRCA1.1</td><td>2 (0–3)</td><td>3 (0–5)</td><td>15.500</td><td>0.325</td></tr><tr><td>BRCA1.2</td><td>17 (13–26)</td><td>13 (13–17)</td><td>8.500</td><td>0.057</... | <table><tr><td>BRCA2.3</td><td>13 (10–28)</td><td>9 (8–14)</td><td>6.500</td><td>0.031*</td></tr><tr><td>BRCA2.4</td><td>8 (6–9)</td><td>5 (5–6)</td><td>2.000</td><td>0.005*</td></tr></table> |
cd221d96c49d250f095afb9c91e31caccc7dd097745c06c4388c8a647868a527.png | complex | <table><tr><td></td><td colspan="2">Algorithm 1</td><td colspan="2">Algorithm 2</td><td colspan="2">Algorithm 3</td><td colspan="2">Algorithm 4</td></tr><tr><td>Descriptor elements count</td><td>avg.</td><td>std. dev.</td><td>avg.</td><td>std. dev.</td><td>avg.</td><td>std. dev.</td><td>avg.</td><td>std. dev.</td></tr>... | <table><tr><td></td><td colspan="2">Algorithm 1</td><td colspan="2">Algorithm 2</td><td colspan="2">Algorithm 3</td><td colspan="2">Algorithm 4</td></tr><tr><td>Descriptor elements count</td><td>avg.</td><td>std. dev.</td><td>avg.</td><td>std. dev.</td><td>avg.</td><td>std. dev.</td><td>avg.</td><td>std. dev.</td></tr>... | <table><tr><td>5</td><td>5.1</td><td>0.8</td><td>8.0</td><td>1.8</td><td>20.5</td><td>4.9</td><td>13.3</td><td>11.2</td></tr><tr><td>6</td><td>5.9</td><td>0.9</td><td>12.4</td><td>2.3</td><td>39.5</td><td>6.1</td><td>42.2</td><td>48.6</td></tr><tr><td>7</td><td>6.1</td><td>0.9</td><td>14.0</td><td>2.5</td><td>61.5</td>... |
097bb9a0cbb9963877b3f48d0e0c39cdab42338064b3334bb23da6104210450e.png | simple | <table><tr><td>Concentration (mg/mL)</td><td>The ratio of green and red fluorescence</td></tr><tr><td>Control</td><td>1.332 ± 0.045</td></tr><tr><td>0.005</td><td>1.420 ± 0.042<sup><i>∗∗</i></sup></td></tr><tr><td>0.025</td><td>1.088 ± 0.037<sup><i>∗∗</i></sup></td></tr><tr><td>0.... | <table><tr><td>Concentration (mg/mL)</td></tr><tr><td>Control</td></tr><tr><td>0.005</td></tr><tr><td>0.025</td></tr><tr><td>0.1</td></tr><tr><td>Positive control</td></tr></table> | <table><tr><td>The ratio of green and red fluorescence</td></tr><tr><td>1.332 ± 0.045</td></tr><tr><td>1.420 ± 0.042∗∗</td></tr><tr><td>1.088 ± 0.037∗∗</td></tr><tr><td>0.801 ± 0.042∗∗</td></tr><tr><td>0.477 ± 0.033∗∗</td></tr></table> |
7fc4b476ff588581918c383afee8343c7cc20ff8fe1ee5034308831abed37d9f.png | simple | <table><tr><td>Clinical Variables</td><td>ET (<i>n</i> = 50)</td><td>ScT (<i>n</i> = 51)</td><td><i>p</i> Value *</td></tr><tr><td>Gestational age, wks, median (IQR)</td><td>28 (26–31)</td><td>26 (24–29)</td><td>0.05</td></tr><tr><td>Birth weight, g, median (IQR)</td><td>1060 (770–2000)</td><td>750 (5... | <table><tr><td>Clinical Variables</td><td>ET (n = 50)</td><td>ScT (n = 51)</td></tr><tr><td>Gestational age, wks, median (IQR)</td><td>28 (26–31)</td><td>26 (24–29)</td></tr><tr><td>Birth weight, g, median (IQR)</td><td>1060 (770–2000)</td><td>750 (580–1100)</td></tr><tr><td>≤1000 g, n (%)</td><td>23 (46)</td><td>37 (7... | <table><tr><td>p Value *</td></tr><tr><td>0.05</td></tr><tr><td>0.003</td></tr><tr><td>0.008</td></tr><tr><td>0.11</td></tr><tr><td>0.11</td></tr><tr><td>0.07</td></tr><tr><td>1</td></tr><tr><td>0.49</td></tr><tr><td>0.83</td></tr><tr><td>0.43</td></tr><tr><td>0.66</td></tr><tr><td>0.57</td></tr><tr><td>0.008</td></tr>... |
a4a9d1f92e39e0d94e656baf074c1c6ce8b707873e058b549ff47eb5ac168acc.png | simple | <table><tr><td>Sample</td><td>Metal organic line pressure (Torr)</td><td>Nanowire diameter (nm)</td><td>Gate-to-nanowire distance (nm)</td><td>Gate length (nm)</td><td>Source-to-drain distance (nm)</td></tr><tr><td>a</td><td>0</td><td>29</td><td>120</td><td>750</td><td>1,200</td></tr><tr><td>b</td><td>0.05</td><td>33</... | <table><tr><td>Sample</td><td>Metal organic line pressure (Torr)</td><td>Nanowire diameter (nm)</td><td>Gate-to-nanowire distance (nm)</td><td>Gate length (nm)</td><td>Source-to-drain distance (nm)</td></tr><tr><td>a</td><td>0</td><td>29</td><td>120</td><td>750</td><td>1,200</td></tr><tr><td>b</td><td>0.05</td><td>33</... | <table><tr><td>Sample</td><td>Metal organic line pressure (Torr)</td><td>Nanowire diameter (nm)</td><td>Gate-to-nanowire distance (nm)</td><td>Gate length (nm)</td><td>Source-to-drain distance (nm)</td></tr><tr><td>e</td><td>0.4</td><td>80</td><td>140</td><td>1,700</td><td>2,500</td></tr></table> |
fd54d563641d3da177efc0a568a4ecdfe965fa1d2838df45c297879e7b304ca1.png | simple | <table><tr><td>Gene<sup>a</sup></td><td>Reference (PubMedID)</td><td>Affected in</td><td>Peak length (bp)</td><td>Peak to transcription start site (bp)</td><td>Promoter class</td></tr><tr><td><i>Nos1</i></td><td>20645313</td><td>Hippocampus</td><td>334</td><td>-3,719</td><td>LCP</td></tr><tr><td><i>Map6</i></td><td>166... | <table><tr><td>Genea</td><td>Reference (PubMedID)</td><td>Affected in</td><td>Peak length (bp)</td></tr><tr><td>Nos1</td><td>20645313</td><td>Hippocampus</td><td>334</td></tr><tr><td>Map6</td><td>16624526</td><td>Hippocampus</td><td>169</td></tr><tr><td>Drd5</td><td>11304828</td><td>Hippocampus</td><td>844</td></tr><tr... | <table><tr><td>Peak to transcription start site (bp)</td><td>Promoter class</td></tr><tr><td>-3,719</td><td>LCP</td></tr><tr><td>-2,382</td><td>ICP</td></tr><tr><td>41</td><td>HCP</td></tr><tr><td>-3,692</td><td>LCP</td></tr><tr><td>-492</td><td>ICP</td></tr><tr><td>-1,042</td><td>HCP</td></tr><tr><td>-3,020</td><td>LC... |
204608a02aa961c5ec5fba9c31e5202cea4b178332377516954e5ee6f1c1d193.png | complex | <table><tr><td>Mentorship demographics</td><td colspan="4">No. (%)</td></tr><tr><td></td><td colspan="4">(N=389 with mentor)</td></tr><tr><td></td><td>Male</td><td>Female</td><td>p</td><td>Fisher Exact Test</td></tr><tr><td>Department of mentor</td><td></td><td></td><td></td><td></td></tr><tr><td>Same department</td><t... | <table><tr><td>Mentorship demographics</td><td colspan="4">No. (%)</td></tr><tr><td></td><td colspan="4">(N=389 with mentor)</td></tr><tr><td></td><td>Male</td><td>Female</td><td>p</td><td>Fisher Exact Test</td></tr></table> | <table><tr><td>Department of mentor</td><td></td><td></td><td></td><td></td></tr><tr><td>Same department</td><td>255 (91.1)</td><td>95 (91.3)</td><td>0.93</td><td>1.0</td></tr><tr><td>Another department</td><td>25 (8.9)</td><td>9 (8.7)</td><td></td><td></td></tr><tr><td>Position of mentor</td><td></td><td></td><td></td... |
a546058032b159423d80e40f4e12d363e193cebf641447eb07cf668086caf1ef.png | complex | <table><tr><td>Characteristics</td><td> </td><td> </td></tr><tr><td>Body mass index </td><td>>30 Kg/m<sup>2</sup></td><td>10 (8.4%)</td></tr><tr><td rowspan="3">Onset of labour</td><td>Spontaneous</td><td>87 (73.1%)</td></tr><tr><td>Induced</td><td>21 (17.6%)</td></tr><tr><td>Augmented</td><td>11 (9.2%)</td></tr><tr... | <table><tr><td>Characteristics</td><td></td><td></td></tr><tr><td>Body mass index</td><td>>30 Kg/m2</td><td>10 (8.4%)</td></tr><tr><td rowspan="3">Onset of labour</td><td>Spontaneous</td><td>87 (73.1%)</td></tr><tr><td>Induced</td><td>21 (17.6%)</td></tr><tr><td>Augmented</td><td>11 (9.2%)</td></tr><tr><td rowspan="3">... | <table><tr><td>Time of decision to perform operative vaginal birth</td><td>2001–0759</td><td>72 (60.5%)</td></tr><tr><td rowspan="3">Length of second stage of labour (in cases where the indication was “failure to progress”)</td><td><3 hr</td><td>5.2%</td></tr><tr><td>3.01–≤4 hr</td><td>14.4%</td></tr><tr><td>≥4.01 hr</... |
f2aebe171bdeaa9ea66ae9318c769a2b5303365da4cd29053aa4fe03e0894a10.png | simple | <table><tr><td>Variables</td><td>NSCLC patients</td><td>Disease controls</td><td>Healthy controls</td><td><i>P</i> value</td></tr><tr><td>Number of subjects</td><td>188</td><td>112</td><td>130</td><td> </td></tr><tr><td>Age (years)</td><td>45.2 ± 12.3</td><td>47.1 ± 11.4</td><td>47.9 ± 13.2</td><td>>0... | <table><tr><td>Variables</td><td>NSCLC patients</td><td>Disease controls</td></tr><tr><td>Number of subjects</td><td>188</td><td>112</td></tr><tr><td>Age (years)</td><td>45.2 ± 12.3</td><td>47.1 ± 11.4</td></tr><tr><td>Sex (M/F)</td><td>118/70</td><td>61/51</td></tr><tr><td>BMI (kg/m2)</td><td>25.3 ± 2.7</td><td>26.1 ±... | <table><tr><td>Healthy controls</td><td>P value</td></tr><tr><td>130</td><td></td></tr><tr><td>47.9 ± 13.2</td><td>>0.05</td></tr><tr><td>72/58</td><td>>0.05</td></tr><tr><td>25.5 ± 2.7</td><td>>0.05</td></tr><tr><td>60/17</td><td>>0.05</td></tr><tr><td>133 ± 12</td><td>>0.05</td></tr><tr><td>79 ± 12</td><td>>0.05</td>... |
6dab946a87ae9540e219145581e1a143457747e54ec8a54a150d5ce639b4f683.png | complex | <table><tr><td>N</td><td>Complications</td><td>Additional comments</td><td>Surgical procedure</td></tr><tr><td rowspan="5">5</td><td rowspan="5">Equipment failure</td><td>Loose halter</td><td>Exploratory laparotomy</td></tr><tr><td>Tail hair broke</td><td>Sarcoid removal</td></tr><tr><td>Tail hair broke</td><td>Tooth e... | <table><tr><td>N</td><td>Complications</td><td>Additional comments</td><td>Surgical procedure</td></tr><tr><td rowspan="5">5</td><td rowspan="5">Equipment failure</td><td>Loose halter</td><td>Exploratory laparotomy</td></tr><tr><td>Tail hair broke</td><td>Sarcoid removal</td></tr><tr><td>Tail hair broke</td><td>Tooth e... | <table><tr><td>N</td><td>Complications</td><td>Additional comments</td><td>Surgical procedure</td></tr><tr><td>4</td><td>lity</td><td>e</td><td>y</td></tr><tr><td rowspan="3">3</td><td rowspan="3">Long recovery</td><td>None</td><td>Tumour removal</td></tr><tr><td>None</td><td>Exploratory laparotomy</td></tr><tr><td>Car... |
9d097b09f106a11764102ffe9f6f2d7831fe92b9cd0c95581b4f2ab29f7015c8.png | complex | <table><tr><td>Variables</td><td colspan="3">SCA2 patients</td><td colspan="3">Preclinical carriers</td><td colspan="3">Healthy controls</td></tr><tr><td></td><td>ICC</td><td>p</td><td>H</td><td>ICC</td><td>p</td><td>H</td><td>ICC</td><td>p</td><td>H</td></tr><tr><td>Saccade velocity (°/s)</td><td>0.47</td><td>0.0... | <table><tr><td>Variables</td><td colspan="3">SCA2 patients</td><td colspan="3">Preclinical carriers</td><td colspan="2">Healthy controls</td></tr><tr><td></td><td>ICC</td><td>p</td><td>H</td><td>ICC</td><td>p</td><td>H</td><td>ICC</td><td>p</td></tr><tr><td>Saccade velocity (°/s)</td><td>0.47</td><td>0.002</td><td>~94%... | <table><tr><td>Healthy controls</td></tr><tr><td>H</td></tr><tr><td>NA</td></tr><tr><td>NA</td></tr><tr><td>NA</td></tr></table> |
e8188beff0ebb1b6a0211777ddcfbf3ccdd38da6a1a4b3c0e0e790a9ede33dad.png | simple | <table><tr><td>Gene identifier</td><td>Gene label</td><td>Description</td><td>Protein identifier</td></tr><tr><td>http://bio2rdf.org/sgd:S000004688</td><td>YMR083W</td><td>Mitochondrial alcohol dehydrogenase isozyme III</td><td>http://bio2rdf.org/sgd:S000004688gp</td></tr><tr><td>http://bio2rdf.org/sgd:S000000349</td><... | <table><tr><td>Gene identifier</td><td>Gene label</td><td>Description</td><td>Protein identifier</td></tr><tr><td>http://bio2rdf.org/sgd:S000004688</td><td>YMR083W</td><td>Mitochondrial alcohol dehydrogenase isozyme III</td><td>http://bio2rdf.org/sgd:S000004688gp</td></tr><tr><td>http://bio2rdf.org/sgd:S000000349</td><... | <table><tr><td>http://bio2rdf.org/sgd:S000000819</td><td>YER017C</td><td>Component of the mitochondrial inner membrane m-AAA protease</td><td>http://bio2rdf.org/sgd:S000000819gp</td></tr><tr><td>http://bio2rdf.org/sgd:S000001306</td><td>YIL044C</td><td>ADP-ribosylation factor (ARF) GTPase activating protein (GAP) effec... |
339c4de5599f1f38977b927aea20f2a11ee104a6da039442b6195bbd1b27f67d.png | simple | <table><tr><td>Histotype<sup>a</sup></td><td>Cell line<sup>b</sup></td><td>IC50 μM (± SE)<sup>c,f</sup></td><td>Genetic alteration<sup>d</sup></td><td>Doubling time (hours)<sup>e,f</sup></td></tr><tr><td>RHABDOMYOSARCOMA</td><td>RD/18</td><td>6.8 (± 2.1)</td><td>Altered 11p15.5 chromosome</td><td>22 ... | <table><tr><td>Histotypea</td><td>Cell lineb</td><td>IC50 μM (± SE)c,f</td><td>Genetic alterationd</td><td>Doubling time (hours)e,f</td></tr><tr><td>RHABDOMYOSARCOMA</td><td>RD/18</td><td>6.8 (± 2.1)</td><td>Altered 11p15.5 chromosome</td><td>22 ± 0.1</td></tr><tr><td></td><td>SJ-RH4</td><td>5.6 (± 1.3)</td><td>(2;13)(... | <table><tr><td></td><td>-71</td><td> 1.4)</td><td>2) EWSR1-FLI1 TYPE I</td><td>9 ± 1.4</td></tr><tr><td></td><td>TC/DOXO8</td><td>5.0 (± 0.1)</td><td>t(11;22)(q24;q12) EWSR1-FLI1 TYPE I</td><td>22.6 ± 2.8</td></tr><tr><td>h-MSC</td><td>MES1</td><td>>50</td><td>n.d.</td><td>n.d.</td></tr><tr><td></td><td>MES2</td><td>>5... |
5bfc00664706295c33fcc43dbec58ca110e3ce1a4cf7188f540481b5ce534c0a.png | complex | <table><tr><td>Spice</td><td>Number of portion sizes</td><td colspan="3">Level of intake (% of portion sizes)</td></tr><tr><td></td><td></td><td><1.0</td><td>1.0-5.0</td><td>>5.0</td></tr><tr><td>R. chillies</td><td>364</td><td>15.1</td><td>69.5</td><td>15.4</td></tr><tr><td>Turmeric</td><td>351</td><td>78.3</td>... | <table><tr><td>Spice</td><td>Number of portion sizes</td><td colspan="3">Level of intake (% of portion sizes)</td></tr><tr><td></td><td></td><td><1.0</td><td>1.0-5.0</td><td>>5.0</td></tr><tr><td>R. chillies</td><td>364</td><td>15.1</td><td>69.5</td><td>15.4</td></tr><tr><td>Turmeric</td><td>351</td><td>78.3</td><td>21... | <table><tr><td>Mustard</td><td></td><td>1.1</td><td>8</td><td></td></tr><tr><td>Cloves</td><td>122</td><td>92.6</td><td>7.4</td><td>-</td></tr><tr><td>Cardamom</td><td>170</td><td>93</td><td>7</td><td>-</td></tr><tr><td>Cinnamon</td><td>118</td><td>75.4</td><td>24.6</td><td>-</td></tr><tr><td>Caraway</td><td>109</td><t... |
ad6a721e4da70017530a9e34c2965bc3d458b0e225dafdda1a019be57d60b600.png | simple | <table><tr><td>Country</td><td>Paliperidone (maximum), %</td></tr><tr><td>Austria</td><td>0.04</td></tr><tr><td>Belgium</td><td>4.8</td></tr><tr><td>Bury PCT</td><td>0.07</td></tr><tr><td>Ireland (GMS population)</td><td>1.01</td></tr><tr><td>Scotland</td><td>0.03</td></tr><tr><td>Spain (Catalonia)</td><td>3.99</td></t... | <table><tr><td>Country</td></tr><tr><td>Austria</td></tr><tr><td>Belgium</td></tr><tr><td>Bury PCT</td></tr><tr><td>Ireland (GMS population)</td></tr><tr><td>Scotland</td></tr><tr><td>Spain (Catalonia)</td></tr><tr><td>Sweden</td></tr></table> | <table><tr><td>Paliperidone (maximum), %</td></tr><tr><td>0.04</td></tr><tr><td>4.8</td></tr><tr><td>0.07</td></tr><tr><td>1.01</td></tr><tr><td>0.03</td></tr><tr><td>3.99</td></tr><tr><td>1.5</td></tr></table> |
ad077e944280c01bc17bb5d02dc7f54fcd715561be8c653225974fa2405fbffe.png | complex | <table><tr><td rowspan="2">Walking Speed (Steps/min)</td><td rowspan="2">Actual ZVI Number</td><td colspan="2">Detected ZVI Number</td></tr><tr><td>Fixed Threshold Method</td><td>Adaptive ZVI Detection Algorithm</td></tr><tr><td>80</td><td>100</td><td>102</td><td>100</td></tr><tr><td>100</td><td>100</td><td>100</td><td... | <table><tr><td rowspan="2">Walking Speed (Steps/min)</td><td rowspan="2">Actual ZVI Number</td></tr><tr></tr><tr><td>80</td><td>100</td></tr><tr><td>100</td><td>100</td></tr><tr><td>120</td><td>100</td></tr></table> | <table><tr><td colspan="2">Detected ZVI Number</td></tr><tr><td>Fixed Threshold Method</td><td>Adaptive ZVI Detection Algorithm</td></tr><tr><td>102</td><td>100</td></tr><tr><td>100</td><td>100</td></tr><tr><td>94</td><td>100</td></tr></table> |
b2c1aa5b812d6d0bd1f5a3d18aa7b1b80caa8b55ba4c986435305af4cea69745.png | simple | <table><tr><td></td><td>Total Epidemic Size</td><td>Days to Epidemic Season Peak</td><td>Length of Epidemic Season</td></tr><tr><td>Regression Intercept (S.E.)</td><td>321.0 (417)</td><td>87.5 (13.5)</td><td>192.3 (24.0)</td></tr><tr><td>Regression Slope (S.E.)</td><td>15383 (7175)</td><td>-255.3 (233)</td><td>-659 (41... | <table><tr><td></td><td>Total Epidemic Size</td><td>Days to Epidemic Season Peak</td></tr><tr><td>Regression Intercept (S.E.)</td><td>321.0 (417)</td><td>87.5 (13.5)</td></tr><tr><td>Regression Slope (S.E.)</td><td>15383 (7175)</td><td>-255.3 (233)</td></tr><tr><td>Regression Model p-value</td><td>0.08</td><td>0.32</td... | <table><tr><td>Length of Epidemic Season</td></tr><tr><td>192.3 (24.0)</td></tr><tr><td>-659 (413)</td></tr><tr><td>0.17</td></tr><tr><td>0.20</td></tr><tr><td>4.2</td></tr><tr><td>8</td></tr></table> |
a3d40bdcd29dd577e60702370809929a125889797a88427bff89817f4f839b9a.png | complex | <table><tr><td> </td><td colspan="3">Men (n = 10,235)</td><td colspan="3">Women (n = 12,234)</td></tr><tr><td> </td><td>Deaths</td><td>Univariate</td><td>Multivariable<sup>b</sup></td><td>Deaths</td><td>Univariate</td><td>Multivariable<sup>b</sup></td></tr><tr><td>Smoking category</td><td> </td><td> </td><td> </td><td>... | <table><tr><td></td><td colspan="3">Men (n = 10,235)</td><td colspan="3">Women (n = 12,234)</td></tr><tr><td></td><td>Deaths</td><td>Univariate</td><td>Multivariableb</td><td>Deaths</td><td>Univariate</td><td>Multivariableb</td></tr><tr><td>Smoking category</td><td></td><td></td><td></td><td></td><td></td><td></td></tr... | <table><tr><td>High versus low</td><td>393/647</td><td>1.43 (1.26, 1.62)</td><td>1.21 (1.06, 1.38)</td><td>72/487</td><td>1.54 (1.20, 1.97)</td><td>1.40 (1.08, 1.80)</td></tr><tr><td>Vegetable/fruit consumption</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Low versus high</td><td>578/462</td><t... |
cae010986e25fd7070e549200c102951c8a71259d766e8ea78f09f41fb4ee1a5.png | complex | <table><tr><td></td><td>Early phase</td><td>Middle phase</td><td>Late phase</td><td>Total</td></tr><tr><td colspan="5">CORRECT RESPONSES</td></tr><tr><td>Literal compliment</td><td>2022.88 (464.33)</td><td>553.59 (146.04)</td><td>754.90 (148.53)</td><td>3226.34 (858.03)</td></tr><tr><td>Literal criticism</td><td>2771.9... | <table><tr><td></td><td>Early phase</td><td>Middle phase</td><td>Late phase</td><td>Total</td></tr><tr><td colspan="5">CORRECT RESP</td></tr></table> | <table><tr><td colspan="5">ONSES</td></tr><tr><td>Literal compliment</td><td>2022.88 (464.33)</td><td>553.59 (146.04)</td><td>754.90 (148.53)</td><td>3226.34 (858.03)</td></tr><tr><td>Literal criticism</td><td>2771.90 (737.72)</td><td>607.19 (165.84)</td><td>975.49 (658.10)</td><td>3879.39 (1050.40)</td></tr><tr><td>Ir... |
d915794865c3cded72fdb49e233a57cda2ed3820429f09f7b400d829839d2065.png | simple | <table><tr><td></td><td>Mean</td><td>Median</td><td>Min</td><td>Max</td><td>Range<sup>*1</sup></td><td>SD<sup>*2</sup></td></tr><tr><td>Referral rate of participating GPs</td><td>0.68</td><td>0.65</td><td>0.53</td><td>0.88</td><td>0.35</td><td>0.11</td></tr><tr><td>Referral rate of non-participating GPs</td><td>0.74</t... | <table><tr><td></td><td>Mean</td><td>Median</td><td>Min</td><td>Max</td><td>Range*1</td></tr><tr><td>Referral rate of participating GPs</td><td>0.68</td><td>0.65</td><td>0.53</td><td>0.88</td><td>0.35</td></tr><tr><td>Referral rate of non-participating GPs</td><td>0.74</td><td>0.76</td><td>0.47</td><td>1.00</td><td>0.5... | <table><tr><td>SD*2</td></tr><tr><td>0.11</td></tr><tr><td>0.15</td></tr></table> |
b167fed36766552fd1199a8bb4e69c7a8f07ab2cf86185657b9909a207da3d53.png | complex | <table><tr><td>Molecular Class</td><td>Number of Molecules Altered Within Each Pathway</td></tr><tr><td colspan="2">Nitrite (80 mg/day)</td></tr><tr><td>Glycerophospholipids</td><td>13</td></tr><tr><td>Sphingolipids</td><td>2</td></tr><tr><td>Glycerolipids</td><td>1</td></tr><tr><td>Fatty Acyls</td><td>3</td></tr><tr><... | <table><tr><td>Molecular Class</td><td>Number of Molecules Altered Within Each Pathway</td></tr><tr><td colspan="2">Nitrite (80 mg/day)</td></tr><tr><td>Glycerophospholipids</td><td>13</td></tr><tr><td>Sphingolipids</td><td>2</td></tr><tr><td>Glycerolipids</td><td>1</td></tr><tr><td>Fatty Acyls</td><td>3</td></tr><tr><... | <table><tr><td>Molecular Class</td><td>Number of Molecules Altered Within Each Pathway</td></tr><tr><td>ate Conjugates</td><td></td></tr><tr><td>Carboxylic Acids and Derivatives</td><td>2</td></tr><tr><td>Imidazole Ribonucleosides and Ribonucleotides</td><td>1</td></tr><tr><td>Pyridines and Derivatives</td><td>1</td></... |
587d62a0820234d4ab6a34de3a8ebb0ba179551896f1de3ddce4adbd5be212bd.png | simple | <table><tr><td>NO.</td><td>TF</td><td>Target</td><td>p. DCG</td><td>Cor.1</td><td>Cor.2</td><td>Type</td><td>NO.</td><td>TF</td><td>Target</td><td>p. DCG</td><td>Cor.1</td><td>Cor.2</td><td>Type</td></tr><tr><td>1</td><td>AHR</td><td>TLE4<sup>*</sup></td><td>6.77E–23</td><td>0.94</td><td>0.14</td><td>0</td><td>26... | <table><tr><td>NO.</td><td>TF</td><td>Target</td><td>p. DCG</td><td>Cor.1</td><td>Cor.2</td><td>Type</td><td>NO.</td></tr><tr><td>1</td><td>AHR</td><td>TLE4*</td><td>6.77E–23</td><td>0.94</td><td>0.14</td><td>0</td><td>26</td></tr><tr><td>2</td><td>ZEB1</td><td>ATP12A*</td><td>3.56E-73</td><td>-0.54</td><td>0.95</td><t... | <table><tr><td>TF</td><td>Target</td><td>p. DCG</td><td>Cor.1</td><td>Cor.2</td><td>Type</td></tr><tr><td>NFYA</td><td>PANK2*</td><td>5.37E–05</td><td>–0.13</td><td>0.97</td><td>1</td></tr><tr><td>MRPL36</td><td>NR4A1*</td><td>1.34E–08</td><td>0.88</td><td>–0.94</td><td>1</td></tr><tr><td>NF1</td><td>NUPL2*</td><td>1.8... |
6ffa98176223405f726212ba0fdacd4aaefa3f0e86f3f5c05590fe988c70766e.png | simple | <table><tr><td> </td><td> </td><td><i>Total number of hits</i></td><td><i>Standard articles retrieved</i></td></tr><tr><td>Keyword search (basic topic + sex differences search)</td><td>Stroke</td><td>301</td><td>33/94</td></tr><tr><td> (stroke AND sex difference<sup>*</sup>); filters: human, Englishor(diabetes AND sex ... | <table><tr><td></td><td></td><td>Total number of hits</td></tr><tr><td>Keyword search (basic topic + sex differences search)</td><td>Stroke</td><td>301</td></tr><tr><td>(stroke AND sex difference*); filters: human, Englishor(diabetes AND sex difference*); filters: human, English</td><td>Diabetes</td><td>539</td></tr><t... | <table><tr><td>Standard articles retrieved</td></tr><tr><td>33/94</td></tr><tr><td>23/95</td></tr><tr><td>50/94</td></tr><tr><td>62/95</td></tr><tr><td>77/94</td></tr><tr><td>81/95</td></tr></table> |
5b2bf2be1be99016b17322f1f92662df9e24f796bfa55f9d87cfedbae52108b7.png | complex | <table><tr><td></td><td>ASD (<i>n</i> = 20)</td><td>TD (<i>n</i> = 23)</td><td colspan="3">Statistics</td></tr><tr><td></td><td>(M, SD)</td><td>(M, SD)</td><td><i>t</i> or<i>χ</i><sup>2</sup></td><td><i>df</i></td><td><i>p</i></td></tr><tr><td>Age (M, SD)</td><td>13.2 ± 2.1</td><td>12.5 ± 2.2</td><td><i>... | <table><tr><td></td></tr><tr><td></td></tr><tr><td>Age (M, SD)</td></tr><tr><td>Gender (males:females)</td></tr><tr><td>CARS (M, SD)</td></tr></table> | <table><tr><td>ASD (n = 20)</td><td>TD (n = 23)</td><td colspan="3">Statistics</td></tr><tr><td>(M, SD)</td><td>(M, SD)</td><td>t orχ2</td><td>df</td><td>p</td></tr><tr><td>13.2 ± 2.1</td><td>12.5 ± 2.2</td><td>t = 1.100</td><td>41</td><td>0.278</td></tr><tr><td>14:6</td><td>17:6</td><td>χ2 = 0.393</td><td>1</td><td>0.... |
35d0ea85d09ec0bfca4e76f2a0b528516ec5b788f4316ca4034ef62dbea31edd.png | simple | <table><tr><td></td><td>Isoch.</td><td>−1.21</td><td>−1.03</td><td>−0.83</td><td>−0.60</td><td>−0.40</td><td>−0.20</td><td>0.00</td><td>0.19</td><td>0.41</td><td>0.59</td><td>0.98</td><td>1.21</td></tr><tr><td>Mean</td><td>253</td><td>267</td><td>272</td><td>272</td><td>272</td><td>2... | <table><tr><td></td><td>Isoch.</td><td>−1.21</td><td>−1.03</td><td>−0.83</td><td>−0.60</td><td>−0.40</td><td>−0.20</td><td>0.00</td><td>0.19</td><td>0.41</td><td>0.59</td><td>0.98</td><td>1.21</td></tr></table> | <table><tr><td>Mean</td><td>253</td><td>267</td><td>272</td><td>272</td><td>272</td><td>258</td><td>272</td><td>273</td><td>272</td><td>263</td><td>271</td><td>260</td><td>266</td></tr><tr><td>SD</td><td>4.37</td><td>19.38</td><td>15.43</td><td>16.14</td><td>15.79</td><td>21.02</td><td>15.96</td><td>16.77</td><td>16.05... |
7e3e9cb69dfca11b95a5f473dbdcbc0066fa3b0ced97a06be46a97e6a2a300d8.png | simple | <table><tr><td>Dietary change</td><td>Epigenetic effects</td><td>Outcome</td><td>Species</td><td>Reference</td></tr><tr><td>Vitamin B<sub>12</sub>, folate and methionine deficient</td><td>DNA methylation</td><td>Hypomethylation in methyl-deficient diet</td><td>Sheep</td><td>Sinclair et al., 2007</td></tr><tr><td>Betain... | <table><tr><td>Dietary change</td><td>Epigenetic effects</td><td>Outcome</td><td>Species</td><td>Reference</td></tr><tr><td>Vitamin B12, folate and methionine deficient</td><td>DNA methylation</td><td>Hypomethylation in methyl-deficient diet</td><td>Sheep</td><td>Sinclair et al., 2007</td></tr><tr><td>Betaine supplemen... | <table><tr><td>c levels</td><td>ylation</td><td>rmethylation in regulatory regions of gene ZIP4</td><td></td><td>rweina et al., 2015</td></tr><tr><td>Restrictive feeding</td><td>Histone modification</td><td>Increased global measures of H3K9 acetylation and reduction in H3K9me3 in IUGR pigs subjected to restrictive feed... |
3a6c99bd52917a5b14fac0e1671d78c491c8364662f7fb870c1f72ce51932925.png | complex | <table><tr><td rowspan="2">Marker</td><td colspan="6">Two-point LOD score values at recombination fraction (θ=)</td><td rowspan="2">Zmax</td><td rowspan="2">θmax</td></tr><tr><td>0.0</td><td>0.1</td><td>0.2</td><td>0.3</td><td>0.4</td><td>0.5</td></tr><tr><td>D1S1677</td><td>-4.21</td><td>1.37</td><td>1.38</t... | <table><tr><td rowspan="2">M</td><td colspan="6">Two-point LOD score values at recombination fraction (θ=)</td><td rowspan="2">Zm</td><td rowspan="2">θmax</td></tr><tr><td>0.0</td><td>0</td><td></td><td></td><td></td><td>0</td></tr></table> | <table><tr><td>arker</td><td></td><td>.1</td><td>0.2</td><td>0.3</td><td>0.4</td><td>.5</td><td>ax</td><td></td></tr><tr><td>D1S1677</td><td>-4.21</td><td>1.37</td><td>1.38</td><td>1.00</td><td>0.45</td><td>0</td><td>1.38</td><td>0.2</td></tr><tr><td>D1S 2878</td><td>4.82</td><td>3.98</td><td>3.05</td><td>2.03</td><td>... |
b994411ee672a367ce266bdf17ceb6f3403a90869ce978af02daf0e21144c239.png | complex | <table><tr><td></td><td colspan="4">Histological results</td></tr><tr><td>HPV Genotype</td><td>< CIN 2(<i>n</i> = 44)</td><td>CIN 2(<i>n</i> = 12)</td><td>CIN 3(<i>n</i> = 18)</td><td>ICC</td></tr><tr><td>HPV 16</td><td>32% (14/44)</td><td>25% (3/12)</td><td>44%(8/18)</td><td></td></tr><tr><td>HPV 53</td><td>25% (11... | <table><tr><td></td><td colspan="4">Histological results</td></tr><tr><td>HPV Genot</td><td>< CI</td><td>CIN 2(n = </td><td>CIN 3(n</td><td>IC</td></tr></table> | <table><tr><td>ype</td><td>N 2(n = 44)</td><td>12)</td><td> = 18)</td><td>C</td></tr><tr><td>HPV 16</td><td>32% (14/44)</td><td>25% (3/12)</td><td>44%(8/18)</td><td></td></tr><tr><td>HPV 53</td><td>25% (11/44)</td><td>17% (2/12)</td><td>28% (5/18)</td><td>1</td></tr><tr><td>HPV 52</td><td>16% (7/44)</td><td>42% (5/12)<... |
bcd6e530fc274c427f53585bde0b07a8b1946aa6eeec4816354044a8e513eb06.png | complex | <table><tr><td rowspan="2">Region</td><td rowspan="2">Methylation status</td><td colspan="2"># CpG in</td><td colspan="4"># of molecules detected</td><td rowspan="2">% of total</td></tr><tr><td>MseI frag.</td><td>Ampl-icon</td><td>Exp 1</td><td>Exp 2</td><td>Exp 3</td><td>Exp 4</td></tr><tr><td rowspan="4">1</td><td>un... | <table><tr><td rowspan="2">Region</td><td rowspan="2">Methylation status</td><td colspan="2"># CpG in</td><td colspan="4"># of molecules detected</td></tr><tr><td>MseI frag.</td><td>Ampl-icon</td><td>Exp 1</td><td>Exp 2</td><td>Exp 3</td><td>Exp 4</td></tr><tr><td rowspan="4">1</td><td>unmethylated</td><td>0</td><td>0<... | <table><tr><td rowspan="2">% of total</td></tr><tr></tr><tr><td rowspan="2">3.0</td></tr><tr></tr><tr><td>3.0</td></tr><tr><td>93.9</td></tr><tr><td rowspan="2">11.8</td></tr><tr></tr><tr><td>5.9</td></tr><tr><td>82.4</td></tr><tr><td>80.4</td></tr><tr><td>0</td></tr><tr><td>0</td></tr><tr><td>19.6</td></tr></table> |
f17c1d3f4486a8048be902e3fd48da6e5edef04baa7218e1decdf582abdf7464.png | complex | <table><tr><td></td><td></td><td></td><td colspan="3">Trial I (unselective supplementation in all mothers from week 18)</td><td></td><td colspan="3">Trial II (selective supplementation in nutritionally at risk mothers from week 28) </td><td></td></tr><tr><td>Trial Group</td><td></td><td></td><td>Protein, Carbohydrate a... | <table><tr><td></td><td></td><td></td><td colspan="3">Trial I (unselective supplementation in all mothers from week 18)</td><td></td><td colspan="3">Trial II (selective supplementation in nutritionally at risk mothers from week 28)</td><td></td></tr><tr><td>Trial Group</td><td></td><td></td><td>Protein, Carbohydrate an... | <table><tr><td></td><td colspan="3">Trial I (unselective supplementation in all mothers from week 18)</td><td></td><td colspan="3">Trial II (selective supplementation in nutritionally at risk mothers from week 28)</td><td></td></tr><tr><td></td><td>Protein, Carbohydrate and Vitamins1</td><td>Carbohydrate and vitamins2<... |
8a266337ee4ce5f5522dae1ba852b593dafdf9a44530d5c5d5ae1999bcf586e0.png | simple | <table><tr><td>Independent variables<sup>1</sup></td><td>Coefficients (SE)</td><td><i>z</i>-value(<i>P</i> value)</td><td>Odds ratio (OR)</td><td>95% CI OR</td></tr><tr><td>Age</td><td>−0.005 (0.01)</td><td>−0.49 (0.63)</td><td>0.99</td><td>(0.98, 1.01)</td></tr><tr><td>Marital status (married)</td><td>0.25... | <table><tr><td>Independent variables1</td><td>Coefficients (SE)</td><td>z-value(P value)</td><td>Odds ratio (OR)</td><td>95% CI OR</td></tr><tr><td>Age</td><td>−0.005 (0.01)</td><td>−0.49 (0.63)</td><td>0.99</td><td>(0.98, 1.01)</td></tr></table> | <table><tr><td>Marital status (married)</td><td>0.25 (0.21)</td><td>1.21 (0.23)</td><td>1.28</td><td>(0.85, 1.93)</td></tr><tr><td>Level of education2</td><td></td><td></td><td></td><td></td></tr><tr><td>12 years formal education</td><td>0.63 (0.25)</td><td>2.52 (0.01)</td><td>1.87</td><td>(1.15, 3.07)</td></tr><tr><td... |
a597d1a2b5b325bf17217ca1db2e33aeb885fd975d954491562509f9dceee423.png | simple | <table><tr><td>Factors</td><td>Domains</td><td>Major themes and their dimensions</td></tr><tr><td>Enabling</td><td>Availability of support</td><td>Formal support</td></tr><tr><td></td><td></td><td> Conflict with centre's hours of operation</td></tr><tr><td></td><td></td><td> Lack of an effective appointment reminder sy... | <table><tr><td>Factors</td><td>Domains</td><td>Major themes and their dimensions</td></tr><tr><td>Enabling</td><td>Availability of support</td><td>Formal support</td></tr><tr><td></td><td></td><td>Conflict with centre's hours of operation</td></tr><tr><td></td><td></td><td>Lack of an effective appointment reminder syst... | <table><tr><td>Factors</td><td>Domains</td><td>Major themes and their dimensions</td></tr><tr><td></td><td></td><td>of severity</td></tr><tr><td></td><td></td><td>Physician judgment of severity</td></tr></table> |
d3519d5bf914ba0312d61fee786a3eb39660705b49cf4ebcec22aad3058250c7.png | simple | <table><tr><td>Method</td><td>P</td><td>R</td><td>F</td><td>Sn</td><td>PPV</td><td>Acc</td></tr><tr><td>MCODE</td><td>0.612</td><td>0.081</td><td>0.142</td><td>0.273</td><td>0.345</td><td>0.307</td></tr><tr><td>CFinder</td><td>0.451</td><td>0.15</td><td>0.225</td><td>0.56</td><td>0.22</td><td>0.351</td></tr><tr><td>CMC... | <table><tr><td>Method</td><td>P</td><td>R</td><td>F</td><td>Sn</td></tr><tr><td>MCODE</td><td>0.612</td><td>0.081</td><td>0.142</td><td>0.273</td></tr><tr><td>CFinder</td><td>0.451</td><td>0.15</td><td>0.225</td><td>0.56</td></tr><tr><td>CMC</td><td>0.224</td><td>0.377</td><td>0.281</td><td>0.472</td></tr><tr><td>RRW</... | <table><tr><td>PPV</td><td>Acc</td></tr><tr><td>0.345</td><td>0.307</td></tr><tr><td>0.22</td><td>0.351</td></tr><tr><td>0.58</td><td>0.523</td></tr><tr><td>0.605</td><td>0.44</td></tr><tr><td>0.498</td><td>0.487</td></tr><tr><td>0.537</td><td>0.551</td></tr><tr><td>0.663</td><td>0.581</td></tr></table> |
59f1e11f26e109b102ce756702bf8bcff5d46f81d422697a51f04881a7723580.png | simple | <table><tr><td>Outcome</td><td>RR</td><td>95% Confidence interval</td><td><i>p</i>-value</td></tr><tr><td>Total cesarean SSIs</td><td>1.10</td><td>0.58–2.08</td><td>0.765</td></tr><tr><td>Cesarean incisional SSIs</td><td>0.23</td><td>0.03–1.78</td><td>0.158</td></tr><tr><td>Cesarean organ/space SSIs</td><td... | <table><tr><td>O</td><td>RR</td><td>95% Confidence in</td><td>p-valu</td></tr></table> | <table><tr><td>utcome</td><td></td><td>terval</td><td>e</td></tr><tr><td>Total cesarean SSIs</td><td>1.10</td><td>0.58–2.08</td><td>0.765</td></tr><tr><td>Cesarean incisional SSIs</td><td>0.23</td><td>0.03–1.78</td><td>0.158</td></tr><tr><td>Cesarean organ/space SSIs</td><td>1.62</td><td>0.83–3.18</td><td>0.160</td></t... |
5233876f014afce1145ad87f6c1562132fd49b46afe5a3f865a5cb2fb71fadaf.png | complex | <table><tr><td>Variable</td><td><i>b</i></td><td><i>SE</i></td><td>Wald</td><td><i>p</i></td><td>Odds ratio (95% CI)</td></tr><tr><td colspan="6">Unadjusted model</td></tr><tr><td>EAL</td><td>0.25</td><td>.20</td><td>1.59</td><td>.207</td><td>1.28 (0.87, 1.89)</td></tr><tr><td>CCC–S score</td><td>−0.20</td>... | <table><tr><td>Variable</td><td>b</td><td>SE</td><td>Wald</td><td>p</td><td>Odds ratio (95% CI)</td></tr><tr><td colspan="6">Unadjusted model</td></tr><tr><td>EAL</td><td>0.25</td><td>.20</td><td>1.59</td><td>.207</td><td>1.28 (0.87, 1.89)</td></tr><tr><td>C</td><td>−</td><td>.01</td><td>1,42</td><td></td><td>0.82 </td... | <table><tr><td>CC–S score</td><td>0.20</td><td></td><td>0.33</td><td>< .001</td><td>(0.81, 0.83)</td></tr><tr><td>CCC–S × EAL</td><td>0.02</td><td>.01</td><td>1.28</td><td>.258</td><td>1.02 (0.99, 1.04)</td></tr><tr><td>Constant</td><td>2.01</td><td>.05</td><td>1,508.96</td><td>< .001</td><td></td></tr><tr><td colspan=... |
583129357eb3dac817f338ca6eca9089b38a27ec98d287c35da98b70df93e0d0.png | simple | <table><tr><td>Sampling sites</td><td>n</td><td>N<sub>A</sub></td><td>P<sub>A</sub> (%)</td><td>A</td><td>H<sub>O</sub></td><td>H<sub>E</sub></td><td>F<sub>IS</sub></td></tr><tr><td>All individuals tested</td><td>313</td><td>64</td><td>—</td><td>5.818</td><td>0.430 ± 0.113</td><td>0.578 ± 0.148</td><td>... | <table><tr><td>Sampling sites</td><td>n</td><td>NA</td><td>PA (%)</td><td>A</td><td>HO</td><td>HE</td><td>FIS</td></tr><tr><td>All individuals tested</td><td>313</td><td>64</td><td>—</td><td>5.818</td><td>0.430 ± 0.113</td><td>0.578 ± 0.148</td><td>0.255</td></tr><tr><td>Microsatellite dataset I</td><td></td><td></td><... | <table><tr><td>Sampling sites</td><td>n</td><td>NA</td><td>PA (%)</td><td>A</td><td>HO</td><td>HE</td><td>FIS</td></tr><tr><td>Adour</td><td>23</td><td>26</td><td>—</td><td>2.364</td><td>0.451 ± 0.233</td><td>0.432 ± 0.198</td><td>−0.045</td></tr><tr><td>Cantabrian rivers</td><td>16</td><td>25</td><td>—</td><td>2.273</... |
6236fefe404781aa4b74eba650f567a3201cc8cb0b591104818bdbd5bd8e465e.png | simple | <table><tr><td>Year</td><td>Milestone</td><td>References</td></tr><tr><td>1994</td><td>Discovery of serum autoantibodies recognizing the nuclear DFS-IIF pattern in patients with interstitial cystitis</td><td>[4]</td></tr><tr><td>1997</td><td>Partial cDNA sequence encoding the autoepitope region of the DFS70 autoantigen... | <table><tr><td>Year</td><td>Milestone</td></tr><tr><td>1994</td><td>Discovery of serum autoantibodies recognizing the nuclear DFS-IIF pattern in patients with interstitial cystitis</td></tr><tr><td>1997</td><td>Partial cDNA sequence encoding the autoepitope region of the DFS70 autoantigen deposited in GenBank under acc... | <table><tr><td>References</td></tr><tr><td>[4]</td></tr><tr><td>[3]</td></tr><tr><td>[13]</td></tr><tr><td>[14]</td></tr><tr><td>[3]</td></tr><tr><td>[32, 98]</td></tr><tr><td>[17-20]</td></tr><tr><td>[125]</td></tr><tr><td>[62]</td></tr><tr><td>[99]</td></tr><tr><td>[7]</td></tr><tr><td>[28]</td></tr><tr><td>[26, 107]... |
97f9d6152ec61258baf865d33d6703551fed035596dd6e9f68c853c51698a918.png | simple | <table><tr><td></td><td>Group I (n=29)</td><td>Group II (n=31)</td><td>Group III (n=24)</td><td>Group IV (n=32)</td><td>Group V (n=27)</td><td>P values *</td></tr><tr><td></td><td>Severe inflammation in semen</td><td>Severe inflammation in EPS and/or post-M</td><td>Mild inflammation in semen, EPS and/or post-M</td><td>... | <table><tr><td></td><td>Group I (n=29)</td><td>Group II (n=31)</td><td>Group III (n=24)</td><td>Group IV (n=32)</td><td>Group V (n=27)</td><td>P values *</td></tr><tr><td></td><td>Severe inflammation in semen</td><td>Severe inflammation in EPS and/or post-M</td><td>Mild inflammation in semen, EPS and/or post-M</td><td>... | <table><tr><td></td><td>Group I (n=29)</td><td>Group II (n=31)</td><td>Group III (n=24)</td><td>Group IV (n=32)</td><td>Group V (n=27)</td><td>P values *</td></tr><tr><td></td><td>Severe inflammation in semen</td><td>Severe inflammation in EPS and/or post-M</td><td>Mild inflammation in semen, EPS and/or post-M</td><td>... |
ab0e0daf03f7068d8953c5de85b8d97624cee44f61b9495ccbd4ba14ae4c2c17.png | complex | <table><tr><td>Characteristic<sup>b</sup></td><td colspan="2">Cases</td><td colspan="2">Controls</td></tr><tr><td></td><td>Adult Glioma Study (<i>n</i> = 622)</td><td>The Cancer Genome Atlas (<i>n</i> = 70)</td><td>Adult Glioma Study (<i>n</i> = 602)</td><td>Illumina iControls (<i>n</i> = 3,390)</td></tr><tr><td>Age</t... | <table><tr><td>Characteristicb</td><td>Cases</td></tr><tr><td></td><td>Adult Glioma Study (n = 622)</td></tr><tr><td>Age</td><td>55 ± 0.5</td></tr><tr><td colspan="2">GENDER</td></tr><tr><td>Male</td><td>398 (64%)</td></tr><tr><td>Female</td><td>224 (36%)</td></tr><tr><td colspan="2">TUMOR SUBTYPE</td></tr><tr><td>Grad... | <table><tr><td>Cases</td><td colspan="2">Controls</td></tr><tr><td>The Cancer Genome Atlas (n = 70)</td><td>Adult Glioma Study (n = 602)</td><td>Illumina iControls (n = 3,390)</td></tr><tr><td>54 ± 1.7</td><td>56 ± 0.6</td><td>29 ± 0.4</td></tr><tr><td colspan="3">GENDER</td></tr><tr><td>40 (57%)</td><td>319 (53%)</td>... |
17756dc40c50a4d7e9b329256cc2f24151505b01d6a16f1c9f1c323c301fbccf.png | complex | <table><tr><td></td><td>Components</td><td rowspan="2">East-West</td><td rowspan="2">North-South</td><td rowspan="2">Vertical</td></tr><tr><td>RMS</td><td></td></tr><tr><td rowspan="2">Relative positioning</td><td>Code (m)</td><td>0.66</td><td>1.07</td><td>1.80</td></tr><tr><td>Carrier-phase (cm)</td><td>1.35</td><td>2... | <table><tr><td></td><td>Components</td><td rowspan="2">East-West</td><td rowspan="2">North-South</td><td rowspan="2">Vertical</td></tr><tr><td>RMS</td><td></td></tr><tr><td rowspan="2">Relative positioning</td><td>Code (m)</td><td>0.66</td><td>1.07</td><td>1.80</td></tr><tr><td>Carrier-phase (cm)</td><td>1.35</td><td>2... | <table><tr><td colspan="2">Velocity estimation (cm/s)</td><td>1.35</td><td>1.70</td><td>3.23</td></tr></table> |
123b563f95e566706941c6433c1d9770727a7c53f4775c9029f28fb6196856c8.png | simple | <table><tr><td>Variable</td><td>ß (95 % CI)</td><td><i>P</i></td><td>Adjusted R<sup>2</sup></td></tr><tr><td>PAP</td><td>2.0 (0.3, 3.8)</td><td>0.025</td><td>0.19</td></tr><tr><td>PCWP</td><td>4.0 (0.8, 7.3)</td><td>0.017</td><td>0.22</td></tr><tr><td>RAP</td><td>5.6 (2.3, 8.9)</td><td>0.002</td><td>0.38</td></tr>... | <table><tr><td>Variable</td><td>ß (95 % CI)</td><td>P</td><td>Adjusted R2</td></tr><tr><td>PAP</td><td>2.0 (0.3, 3.8)</td><td>0.025</td><td>0.19</td></tr></table> | <table><tr><td>PCWP</td><td>4.0 (0.8, 7.3)</td><td>0.017</td><td>0.22</td></tr><tr><td>RAP</td><td>5.6 (2.3, 8.9)</td><td>0.002</td><td>0.38</td></tr></table> |
74bba954da6b23c64a607ba853337a98b306de03c2626960b05b82eacbc4f032.png | complex | <table><tr><td></td><td>Estimate</td><td>Standard error</td><td><i>z</i> Value</td><td>Pr(>|<i>z</i>|)</td></tr><tr><td colspan="2">Reference value: the fifth graders</td><td></td><td></td><td></td></tr><tr><td>Intercept</td><td>-0.89</td><td>0.13</td><td>-6.68</td><td>0.000***</td></tr><tr><td>Strategy</td><td>-0.3... | <table><tr><td></td><td>Estimate</td><td>Standard error</td></tr><tr><td colspan="2">Reference value: the fifth graders</td><td></td></tr><tr><td>Intercept</td><td>-0.89</td><td>0.13</td></tr><tr><td>Strategy</td><td>-0.37</td><td>0.09</td></tr><tr><td>Cued strategy</td><td>1.18</td><td>0.09</td></tr><tr><td>Correct su... | <table><tr><td>z Value</td><td>Pr(>|z|)</td></tr><tr><td></td><td></td></tr><tr><td>-6.68</td><td>0.000***</td></tr><tr><td>-4.36</td><td>0.000***</td></tr><tr><td>13.69</td><td>0.000***</td></tr><tr><td>2.11</td><td>0.035*</td></tr><tr><td>0.74</td><td>0.458</td></tr><tr><td>-0.89</td><td>0.371</td></tr><tr><td></td><... |
b879c40213026aa4145abbf9cc4aec24979b524f7f7001f04f5ffb28c6f37eea.png | simple | <table><tr><td>Disease category</td><td># of specific genes</td><td>Total genes</td><td>% of specific genes</td></tr><tr><td>ASD</td><td>189</td><td>321</td><td>69.8</td></tr><tr><td>FASD</td><td>27</td><td>106</td><td>25.5</td></tr><tr><td>CP</td><td>23</td><td>124</td><td>22.1</td></tr></table> | <table><tr><td>Disease category</td><td># of specific genes</td><td>Total genes</td><td>% of specific genes</td></tr></table> | <table><tr><td>ASD</td><td>189</td><td>321</td><td>69.8</td></tr><tr><td>FASD</td><td>27</td><td>106</td><td>25.5</td></tr><tr><td>CP</td><td>23</td><td>124</td><td>22.1</td></tr></table> |
66110f9d38868543894ab26c0bb35ffd9c5c208e75a10776962739a4269e36c0.png | simple | <table><tr><td> </td><td>Gr A (<i>N</i> = 32)</td><td>Gr B (<i>N</i> = 87)</td><td><i>P</i> value</td></tr><tr><td>Mean follow-up </td><td>710 ± 242</td><td>766 ± 426 days</td><td>0.48</td></tr><tr><td>Binary restenosis rate (by duplex US PSV ratio>2.5)</td><td> </td><td> </td><td> </td></tr><tr><td> 6 mon... | <table><tr><td></td><td>Gr A (N = 32)</td><td>Gr B (N = 87)</td></tr><tr><td>Mean follow-up</td><td>710 ± 242</td><td>766 ± 426 days</td></tr><tr><td>Binary restenosis rate (by duplex US PSV ratio>2.5)</td><td></td><td></td></tr><tr><td>6 months</td><td>11/30 = 37%</td><td>11/80 = 14%</td></tr><tr><td>12 months</td><td... | <table><tr><td>P value</td></tr><tr><td>0.48</td></tr><tr><td></td></tr><tr><td>0.007</td></tr><tr><td>0.001</td></tr><tr><td>0.028</td></tr><tr><td></td></tr><tr><td>0.005</td></tr><tr><td>0.018</td></tr><tr><td>0.11</td></tr><tr><td></td></tr><tr><td>0.51</td></tr><tr><td>0.71</td></tr></table> |
1b3f87186a260e1089461fb36cb20bd9721e0ec66e33f2ff28f44bae35bf2c16.png | simple | <table><tr><td>Metabolite</td><td>Gene involved in biosynthesis</td><td>Locus number</td><td>Biological Evidence</td><td>Reference</td></tr><tr><td>Pyoverdine</td><td><i>pvdSL; pvdIJKDEONMP; fpvI; pvdA</i></td><td>PSF113_1749-1750; PSF113_1836-1847; PSF113_1856-1860</td><td>Yes</td><td>[2]</td></tr><tr><td>Pyridine-2,6... | <table><tr><td>Metabolite</td><td>Gene involved in biosynthesis</td><td>Locus number</td><td>Biological Evidence</td><td>Reference</td></tr></table> | <table><tr><td>Pyoverdine</td><td>pvdSL; pvdIJKDEONMP; fpvI; pvdA</td><td>PSF113_1749-1750; PSF113_1836-1847; PSF113_1856-1860</td><td>Yes</td><td>[2]</td></tr><tr><td>Pyridine-2,6-bis-thiocarboxylic acid (PDTC)</td><td>pdtCKPELMFGHIJON</td><td>PSF113_2605-2618</td><td>No</td><td></td></tr><tr><td>2,4 diacetyl-phlorogl... |
c46606c95a180a7dff344bdadd8a4465a4e68bfbabc68ef1d4966cac6d050ab1.png | simple | <table><tr><td>Parameter</td><td><i>P</i></td><td>Odds ratio (OR)</td><td>95% confidence interval (CI)</td></tr><tr><td>Maternal age</td><td>0.846</td><td>0.995</td><td>0.943–1.050</td></tr><tr><td>Multiparity</td><td>0.293</td><td>0.751</td><td>0.459–1.235</td></tr><tr><td>Previous uterine surgery (includi... | <table><tr><td>Parameter</td><td>P</td><td>Odds ratio (OR)</td><td>95% confidence interval (CI)</td></tr><tr><td>Maternal age</td><td>0.846</td><td>0.995</td><td>0.943–1.050</td></tr><tr><td>Multiparity</td><td>0.293</td><td>0.751</td><td>0.459–1.235</td></tr><tr><td>Previous uterine surgery (including myomectomy, caes... | <table><tr><td>Transfer of 2 embryos</td><td>0.043</td><td>1.952</td><td>0.020–3.735</td></tr><tr><td>Spontaneous cycle ET</td><td>0.064</td><td>0.417</td><td>0.150–1.164</td></tr></table> |
161122bdfa32c8e0a4937df023fa662eff5ad3fb3366c56813acc0c4f6c0c3aa.png | simple | <table><tr><td></td><td>Abrupt</td><td>Gradual 1</td><td>Gradual 2</td><td>All treatments</td></tr><tr><td>Randomized, <i>n</i></td><td>41</td><td>40</td><td>42</td><td>123</td></tr><tr><td>Safety population, <i>n</i></td><td>40</td><td>39</td><td>42</td><td>121</td></tr><tr><td>Completed, %</td><td>75</td><td>72</td><... | <table><tr><td></td><td>Abrupt</td></tr><tr><td>Randomized, n</td><td>41</td></tr><tr><td>Safety population, n</td><td>40</td></tr><tr><td>Completed, %</td><td>75</td></tr><tr><td>Discontinued, %</td><td>25</td></tr><tr><td>Adverse event</td><td>5</td></tr><tr><td>Withdrew consent</td><td>10</td></tr><tr><td>Insufficie... | <table><tr><td>Gradual 1</td><td>Gradual 2</td><td>All treatments</td></tr><tr><td>40</td><td>42</td><td>123</td></tr><tr><td>39</td><td>42</td><td>121</td></tr><tr><td>72</td><td>88</td><td>79</td></tr><tr><td>28</td><td>12</td><td>21</td></tr><tr><td>15</td><td>5</td><td>8</td></tr><tr><td>8</td><td>0</td><td>6</td><... |
3aedbf6a1cb025be037e4e984aefae7a8b4b20f89568da533dde1881daab16e0.png | complex | <table><tr><td></td><td></td><td colspan="6">Survival rate</td></tr><tr><td></td><td>Total mRNA injected (pg)</td><td>1 day</td><td>2 days<sup>a</sup></td><td>4 days</td><td>6 days</td><td>15 days</td><td>18 weeks</td></tr><tr><td>WT</td><td>N.A.</td><td>86% (6/7)</td><td>80% (4/5)</td><td>80% (4/5)</td><td>80% (4/5)</... | <table><tr><td></td><td></td><td colspan="6">Survival rate</td></tr><tr><td></td><td>Total mRNA injected (pg)</td><td>1 day</td><td>2 daysa</td><td>4 days</td><td>6 days</td><td>15 days</td><td>18 weeks</td></tr><tr><td>WT</td><td>N.A.</td><td>86% (6/7)</td><td>80% (4/5)</td><td>80% (4/5)</td><td>80% (4/5)</td><td>80% ... | <table><tr><td>TALEN2</td><td>300</td><td>100% (8/8)</td><td>33% (2/6)</td><td>0% (0/6)</td><td>0% (0/6)</td><td>0% (0/6)</td><td>0% (0/6)</td></tr><tr><td></td><td>200</td><td>88% (7/8)</td><td>67% (4/6)</td><td>0% (0/6)</td><td>0% (0/6)</td><td>0% (0/6)</td><td>0% (0/6)</td></tr><tr><td></td><td>100</td><td>100% (8/8... |
246ae9347cd89c658a6cde006d62fc252de87a8031cb486e16d3bc8ae8350347.png | simple | <table><tr><td>Cat Demographics</td><td>Free Cats <i>n</i> = 73 (%)</td><td>Normal-Fee Cats <i>n</i> = 78 (%)</td></tr><tr><td>Cat Ages</td><td></td><td></td></tr><tr><td>Age range</td><td>1–16 years</td><td>1–14 years</td></tr><tr><td>Age mean</td><td>4 years</td><td>3 years</td></tr><tr><td>Cat Sex</td><t... | <table><tr><td>Cat Demographics</td><td>Free Cats n = 73 (%)</td><td>Normal-Fee Cats n = 78 (%)</td></tr><tr><td>Cat Ages</td><td></td><td></td></tr><tr><td>Age range</td><td>1–16 years</td><td>1–14 years</td></tr><tr><td>Age mean</td><td>4 years</td><td>3 years</td></tr><tr><td>Cat Sex</td><td></td><td></td></tr><tr><... | <table><tr><td>Cat Demographics</td><td>Free Cats n = 73 (%)</td><td>Normal-Fee Cats n = 78 (%)</td></tr><tr><td>tures</td><td></td><td>)</td></tr><tr><td>TOTAL males</td><td>21 (29)</td><td>21 (27)</td></tr><tr><td>Male adults</td><td>16 (22)</td><td>19 (24)</td></tr><tr><td>Male matures</td><td>5 (7)</td><td>2 (3)</t... |
6f1b5853e66a93084dd9b70b1d750f613bf1f7ae46f02d690d9e1f8aa6c79718.png | simple | <table><tr><td>Variable</td><td>Total (N = 118)</td><td>Non–diabetes mellitus (N = 109)</td><td>Diabetes mellitus (N = 9)</td><td>P</td></tr><tr><td>Gastric lavage, n (%)</td><td>95 (80.5)</td><td>89 (81.7)</td><td>6 (66.7)</td><td>0.275</td></tr><tr><td>Active charcoal and magnesium citrate, n (%)</td><td>88 (74... | <table><tr><td>Variable</td><td>Total (N = 118)</td><td>Non–diabetes mellitus (N = 109)</td><td>Diabetes mellitus (N = 9)</td><td>P</td></tr><tr><td>Gastric lavage, n (%)</td><td>95 (80.5)</td><td>89 (81.7)</td><td>6 (66.7)</td><td>0.275</td></tr><tr><td>Active charcoal and magnesium citrate, n (%)</td><td>88 (74.6)</t... | <table><tr><td>(median, IQR)</td><td>0 (2.0, 5.0)</td><td>)</td><td>3.5 (2.0, 9.0)</td><td>3</td></tr><tr><td>Duration of follow-up, months (median, IQR)</td><td>1.25 (0.40, 9.06)</td><td>1.23 (0.43, 8.63)</td><td>2.27 (0.25, 15.67)</td><td>0.219</td></tr><tr><td>Mortality, n (%)</td><td>18 (15.3)</td><td>15 (13.8)</td... |
59130f4646d11f958d9e6387e451f7839ba95e70865bd78aaeced4f16747f36a.png | simple | <table><tr><td> </td><td>Bariatric Surgery (N = 34)</td><td>Lifestyle Intervention (N = 34)</td><td><i>P</i></td></tr><tr><td>Age (yrs)</td><td>43.3 ± 9.4</td><td>40.9 ± 10.5</td><td>0.33</td></tr><tr><td>% Female</td><td>76.5</td><td>76.5</td><td>1.00</td></tr><tr><td>% Race</td><td> </td><td> </td><td>0.25<... | <table><tr><td></td><td>Bariatric Surgery (N = 34)</td><td>Lifestyle Intervention (N = 34)</td><td>P</td></tr><tr><td>Age (yrs)</td><td>43.3 ± 9.4</td><td>40.9 ± 10.5</td><td>0.33</td></tr><tr><td>% Female</td><td>76.5</td><td>76.5</td><td>1.00</td></tr><tr><td>% Race</td><td></td><td></td><td>0.25</td></tr><tr><td>Whi... | <table><tr><td>% Ethnicity</td><td></td><td></td><td>1.00</td></tr><tr><td>Non-Hispanic</td><td>91.2</td><td>91.2</td><td></td></tr><tr><td>Hispanic</td><td>8.8</td><td>8.8</td><td></td></tr><tr><td>BMI (kg/m2)</td><td>46.2 ± 7.8</td><td>45.0 ± 4.9</td><td>0.49</td></tr><tr><td>Weight (kg)</td><td>129.9 ± 27.6</td><td>... |
0d0676f63c053a76d06725adab713768afd33de1defb43a36177b19735cc9c5c.png | simple | <table><tr><td></td><td>American (N = 419)*</td><td>Taiwanese (N = 2062)</td><td>P-value</td></tr><tr><td>Age</td><td>53.2 ± 13.7</td><td>47.6 ± 13.6</td><td></td></tr><tr><td>Gender</td><td></td><td></td><td><.0001</td></tr><tr><td> Female</td><td>64.6% (265/410)</td><td>51.5%</td><td></td></tr><tr><td> M... | <table><tr><td></td></tr><tr><td>Age</td></tr><tr><td>Gender</td></tr><tr><td>Female</td></tr><tr><td>Male</td></tr><tr><td>Acute myocardial infarction</td></tr><tr><td>Comorbidities</td></tr><tr><td>Hypertension</td></tr><tr><td>Diabetes mellitus</td></tr><tr><td>Dyslipidemia</td></tr><tr><td>Arrhythmia</td></tr><tr><... | <table><tr><td>American (N = 419)*</td><td>Taiwanese (N = 2062)</td><td>P-value</td></tr><tr><td>53.2 ± 13.7</td><td>47.6 ± 13.6</td><td></td></tr><tr><td></td><td></td><td><.0001</td></tr><tr><td>64.6% (265/410)</td><td>51.5%</td><td></td></tr><tr><td>35.4% (145/410)</td><td>48.5%</td><td></td></tr><tr><td>6% (24/399)... |
420cd88d91f3d95177cc61d087c99b2de2d7f96ba3f9c4175972bb0c7cfd6499.png | simple | <table><tr><td>Registered indications</td><td>Prophylaxis of bleeding related to surgical or invasive interventions as well as treatment of bleeding in patients with</td></tr><tr><td></td><td>-Congenital hemophilia A or B if inhibitors are present (>5 Bethesda units) or if a strong increase of inhibitors must be exp... | <table><tr><td>Registered indications</td><td>Prophylaxis of bleeding related to surgical or invasive interventions as well as treatment of bleeding in patients with</td></tr><tr><td></td><td>-Congenital hemophilia A or B if inhib</td></tr></table> | <table><tr><td></td><td>itors are present (>5 Bethesda units) or if a strong increase of inhibitors must be expected upon administration of factor VIII or IX [41]</td></tr><tr><td></td><td>- Acquired hemophilia [42]</td></tr><tr><td></td><td>- Congenital factor VII deficiency [43]</td></tr><tr><td></td><td>- Glanzmann ... |
8b7f80c7aa095c949c6271ca55e2f9708aa283c33878f7b2f8f40f2528f96df4.png | simple | <table><tr><td></td><td>Hol</td><td>Tul</td><td>Ban</td><td>Bis</td><td>Gau</td><td>Mit</td><td>Yak</td><td>Anc</td><td>BubB</td><td>BubC</td><td>Ind</td><td>Mur</td><td>Syn</td><td>Ela</td></tr><tr><td>T<sub>N</sub></td><td>-0.13</td><td>0.1</td><td>1.4</td><td>1.2</td><td>1.6</td><td>1.0</td><td>0.9</td><td>2.4</td><... | <table><tr><td></td><td>Hol</td><td>Tul</td><td>Ban</td><td>Bis</td><td>Gau</td><td>Mit</td><td>Yak</td><td>Anc</td><td>BubB</td><td>BubC</td><td>Ind</td><td>Mur</td><td>Syn</td><td>Ela</td></tr></table> | <table><tr><td>TN</td><td>-0.13</td><td>0.1</td><td>1.4</td><td>1.2</td><td>1.6</td><td>1.0</td><td>0.9</td><td>2.4</td><td>4.2</td><td>3.9</td><td>5.0</td><td>4.2</td><td>4.1</td><td>7.4</td></tr><tr><td>TC</td><td>-0.25</td><td>0.15</td><td>2.6</td><td>2.1</td><td>3.0</td><td>1.9</td><td>1.6</td><td>4.5</td><td>7.7</... |
b97a0d397bf601bdfdd54e9077f24470ce8443ddc61fd8e6ddc9d60ed901b98f.png | complex | <table><tr><td colspan="7">Compression Bulge Anterior BulgeL</td></tr><tr><td>Var.</td><td>Df</td><td>Sum of Sq.</td><td>Mean Square</td><td>F Value</td><td><i>p</i>-Value</td><td>Significance Code</td></tr><tr><td>C10</td><td>1</td><td>0.00066</td><td>0.00066</td><td>35.8</td><td>2.41 × 10<sup>−8</sup></td>... | <table><tr><td colspan="7">Compression Bulge Anterior BulgeL</td></tr><tr><td>Var.</td><td>Df</td><td>Sum of Sq.</td><td>Mean Square</td><td>F Value</td><td>p-Value</td><td>Significance Code</td></tr><tr><td>C10</td><td>1</td><td>0.00066</td><td>0.00066</td><td>35.8</td><td>2.41 × 10−8</td><td>***</td></tr><tr><td>C0</... | <table><tr><td>Cartil_μ</td><td>1</td><td>0.00054</td><td>0.00054</td><td>29.4</td><td>3.24 × 10−7</td><td>***</td></tr><tr><td>Residuals</td><td>117</td><td>0.00214</td><td>0.00002</td><td></td><td></td><td></td></tr></table> |
bde0b3eebafad643c0a2fcf7ed46e3639a337fdc2de0ab1bb848e6dee5edf620.png | complex | <table><tr><td>Domain/outcome</td><td>Questionnaire/items</td><td colspan="4">Assessment time point</td><td>Reference</td></tr><tr><td>Primary Outcome</td><td> </td><td>t1</td><td>t2</td><td>t3</td><td>t4</td><td> </td></tr><tr><td>Physical functioning</td><td>Hannover Functional Ability Questionnaire (FfbH-R)</td><td>... | <table><tr><td>Domain/outcome</td><td>Questionnaire/items</td><td colspan="4">Assessment time point</td><td>Reference</td></tr><tr><td>Primary Outcome</td><td></td><td>t1</td><td>t2</td><td>t3</td><td>t4</td><td></td></tr><tr><td>Physical functioning</td><td>Hannover Functional Ability Questionnaire (FfbH-R)</td><td>x<... | <table><tr><td>Pain status</td><td>Graded Chronic Pain Status (GCPS)</td><td>x</td><td>x</td><td>x</td><td>x</td><td>[53]</td></tr><tr><td>Physical activity</td><td>Freiburg questionnaire on physical activity (FFkA)</td><td>x</td><td></td><td>x</td><td>x</td><td>[54]</td></tr><tr><td>Emotional functioning</td><td></td>... |
410f9c2c057f0bbf76e3dffcae484f296f29fb088ed40afe2f9f03a6cee75d86.png | complex | <table><tr><td></td><td>Incremental Difference: Complete Ban<i>vs.</i>Current Legislation</td><td>Incremental Difference: Optimistic Case</td><td>Incremental Difference: Worst Case</td></tr><tr><td>Gross Intervention Costs (C)</td><td>3,994,645</td><td>1,996,438</td><td>5,067,102</td></tr><tr><td>AMI Treatment Costs Sa... | <table><tr><td></td><td>Incremental Difference: Complete Banvs.Current Legislation</td><td>Incremental Difference: Optimistic Case</td><td>Incremental Difference: Worst Case</td></tr><tr><td>Gross Intervention Costs (C)</td><td>3,994,645</td><td>1,996,438</td><td>5,067,102</td></tr><tr><td>AMI Treatment Costs Saved (T)... | <table><tr><td>ll Tobacco-Attributable Treatment Costs Saved (T)</td><td>9,609,250</td><td>37</td><td>,527,779</td></tr><tr><td>Net Costs (AMI Treatment) *(C-T)</td><td>–36,056,957</td><td>–235,931,160</td><td>3,440,362</td></tr><tr><td>Net Costs (All Tobacco-Attributable Disease Treatment) * (C-T)</td><td>–95,614,605<... |
8e4093a3580770572bbac5e2db9ffaaf1df2252db35e4bc8df4a0231c139aa69.png | simple | <table><tr><td></td><td><i>stx1a</i></td><td><i>stx2a</i></td><td><i>stx2d</i></td><td><i>stx1a+2a</i></td><td><i>stx1a+2d</i></td><td><i>stx</i> negative</td><td>Total</td></tr><tr><td>ST21</td><td>353</td><td>20</td><td>2</td><td>44</td><td>1</td><td>17</td><td>437</td></tr><tr><td>SLV of ST21</td><td>5</td><td>1</td... | <table><tr><td></td><td>stx1a</td><td>stx2a</td></tr><tr><td>ST21</td><td>353</td><td>20</td></tr><tr><td>SLV of ST21</td><td>5</td><td>1</td></tr><tr><td>ST29</td><td>1</td><td>27</td></tr><tr><td>SLV of ST29</td><td>0</td><td>0</td></tr><tr><td>Total</td><td>359</td><td>48</td></tr></table> | <table><tr><td>stx2d</td><td>stx1a+2a</td><td>stx1a+2d</td><td>stx negative</td><td>Total</td></tr><tr><td>2</td><td>44</td><td>1</td><td>17</td><td>437</td></tr><tr><td>0</td><td>0</td><td>0</td><td>0</td><td>6</td></tr><tr><td>3</td><td>0</td><td>0</td><td>45</td><td>76</td></tr><tr><td>0</td><td>0</td><td>0</td><td>... |
5107191eb02e7f20f41bc405df2b6d0ddd5d193ab2e75d652d4bb13bca35b2a0.png | simple | <table><tr><td></td><td><i>T. trichiura</i> Uganda</td><td><i>T. trichiura</i> China</td><td><i>T. trichiura</i> Ecuador</td></tr><tr><td><i>T. trichiura</i> Uganda</td><td></td><td>0.979**</td><td>0.932***</td></tr><tr><td><i>T. trichiura</i> China</td><td>0.984**</td><td></td><td>0.551*</td></tr><tr><td><i>T. trichiu... | <table><tr><td></td><td>T. trichiura Uganda</td><td>T. trichiura China</td><td>T. trichiura Ecuador</td></tr><tr><td>T. tri</td><td></td><td>0.</td><td>0.</td></tr></table> | <table><tr><td>chiura Uganda</td><td></td><td>979**</td><td>932***</td></tr><tr><td>T. trichiura China</td><td>0.984**</td><td></td><td>0.551*</td></tr><tr><td>T. trichiura Ecuador</td><td>0.967***</td><td>0.778*</td><td></td></tr></table> |
d16ec135ea8dc15b7dddda4f7a4e7fece53c25d26ba11f7fee8e612c27f33c5f.png | complex | <table><tr><td rowspan="2">Experimental treatment </td><td><i>Staphylococcus aureus </i></td><td><i>Streptococcus agalactiae </i></td><td>Group G Streptococci</td><td><i>Streptococcus pyogenes </i></td><td><i>Streptococcus pneumoniae </i></td><td>Biofilm-forming strain<i>S. aureus </i>(ATCC 25923)</td><td>Nonbiofilm-fo... | <table><tr><td rowspan="2">Experimental treatment</td><td>Staphylococcus aureus</td><td>Streptococcus agalactiae</td><td>Group G Streptococci</td><td>Streptococcus pyogenes</td><td>Streptococcus pneumoniae</td><td>Biofilm-forming strainS. aureus (ATCC 25923)</td><td>Nonbiofilm-forming strainE. coli (ATCC 25922)</td></t... | <table><tr><td rowspan="2">Experimental treatment</td><td>Staphylococcus aureus</td><td>Streptococcus agalactiae</td><td>Group G Streptococci</td><td>Streptococcus pyogenes</td><td>Streptococcus pneumoniae</td><td>Biofilm-forming strainS. aureus (ATCC 25923)</td><td>Nonbiofilm-forming strainE. coli (ATCC 25922)</td></t... |
214a7b1c8ac73b3f877a0488037dbe51554ca4c75f4aa91dada5122d513e9d96.png | complex | <table><tr><td></td><td></td><td colspan="3">Aurora A and p27 expression</td><td rowspan="2"><i>P</i></td></tr><tr><td></td><td></td><td>2H</td><td>1H1L</td><td>2L</td></tr><tr><td colspan="6">Sex</td></tr><tr><td>Male</td><td>63</td><td>54</td><td>7</td><td>2</td><td rowspan="2">0.191</td></tr><tr><td>Female</td><td>1... | <table><tr><td></td><td></td><td colspan="3">Aurora A and p27 expression</td><td rowspan="2">P</td></tr><tr><td></td><td></td><td>2H</td><td>1H1L</td><td>2L</td></tr><tr><td colspan="6">Sex</td></tr><tr><td>Male</td><td>63</td><td>54</td><td>7</td><td>2</td><td rowspan="2">0.191</td></tr><tr><td>Female</td><td>17</td><... | <table><tr><td></td><td></td><td colspan="3">Aurora A and p27 expression</td><td rowspan="2">P</td></tr><tr><td></td><td></td><td>2H</td><td>1H1L</td><td>2L</td></tr><tr><td>Middle</td><td>22</td><td>19</td><td>3</td><td>0</td><td rowspan="2">0.687</td></tr><tr><td>Down</td><td>39</td><td>35</td><td>4</td><td>0</td></t... |
1d211d2b59e24841d2b261112fc14ec52b4cf6ddc157092a0b497c35fa2513a4.png | simple | <table><tr><td>Inhalation repeats</td><td>PIF cut-off value (L/min)</td><td>Sensitivity (%)</td><td>Specificity (%)</td><td>AUC</td><td>Positive predictive value (%)</td><td>Negative predictive value (%)</td></tr><tr><td>I</td><td>140</td><td>84</td><td>53</td><td>0.69</td><td>81</td><td>59</td></tr><tr><td>II</td><td>... | <table><tr><td>Inhalation repeats</td><td>PIF cut-off value (L/min)</td><td>Sensitivity (%)</td><td>Specificity (%)</td><td>AUC</td><td>Positive predictive value (%)</td><td>Negative predictive value (%)</td></tr><tr><td>I</td><td>140</td><td>84</td><td>53</td><td>0.69</td><td>81</td><td>59</td></tr><tr><td>II</td><td>... | <table><tr><td>IV</td><td>100</td><td>87</td><td>71</td><td>0.86</td><td>48</td><td>95</td></tr></table> |
1a96bd8c03cb29dd2c29bf02b1143e4197ba499263f03ec1aea7b11ebee03604.png | complex | <table><tr><td></td><td>Q1 <sup>a</sup></td><td>Q2 <sup>a</sup></td><td>Q3 <sup>a</sup></td><td>Q4 <sup>a</sup></td><td><i>P</i><sup>b</sup></td><td>n</td><td>β % <sup>c</sup></td><td colspan="2">95% CI</td></tr><tr><td colspan="10">Men n=2 264</td></tr><tr><td>PNNS-GS range</td><td>≤8.05</td><td>[8.05-9.30]... | <table><tr><td></td><td>Q1 a</td><td>Q2 a</td><td>Q3 a</td><td>Q4 a</td><td>Pb</td><td>n</td><td>β % c</td><td colspan="2">95% CI</td></tr><tr><td colspan="10">Men n=2 264</td></tr><tr><td>PNNS-GS range</td><td>≤8.05</td><td>[8.05-9.30]</td><td>[9.30-10.70]</td><td>>10.70</td><td></td><td></td><td></td><td></td><td></t... | <table><tr><td>tR</td><td>0.54 (0.54-0.55)</td><td>4)</td><td>.52-0.54)</td><td>2 (0.51-0.52)</td><td>.0001</td><td>64</td><td>.26</td><td>0.00</td><td>47</td></tr><tr><td>% body fat</td><td>21.2 (20.1-22.4)</td><td>19.7 (18.7-20.8)</td><td>19.7 (18.6-20.7)</td><td>17.7 (16.8-18.7)</td><td><.0001</td><td>2235</td><td>-... |
acad95f15152ff50950a7626d4686915c8a7aa2e712553eee9f44b1249d2fac7.png | simple | <table><tr><td></td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td><td>9</td><td>10</td><td>11</td><td>12</td><td>13</td><td>14</td><td>15</td><td>16</td><td>17</td><td>18</td><td>19</td><td>20</td><td>21</td></tr><tr><td>A</td><td>224</td><td>228</td><td>186</td><td>146</td><td>213</td... | <table><tr><td></td><td>1</td><td>2</td><td>3</td><td>4</td><td>5</td><td>6</td><td>7</td><td>8</td><td>9</td><td>10</td><td>11</td><td>12</td><td>13</td><td>14</td><td>15</td><td>16</td><td>17</td><td>18</td><td>19</td><td>20</td><td>21</td></tr><tr><td>A</td><td>224</td><td>228</td><td>186</td><td>146</td><td>213</td... | <table><tr><td>Con</td><td>N</td><td>N</td><td>N</td><td>N</td><td>N</td><td>T</td><td>A</td><td>T</td><td>A</td><td>A</td><td>A</td><td>D</td><td>W</td><td>N</td><td>N</td><td>N</td><td>N</td><td>N</td><td>N</td><td>N</td><td>N</td></tr></table> |
da4419c230b904407d5f3ad3ead513264ccf579b47fc2593344806ac5004ca60.png | complex | <table><tr><td colspan="8">FIGO stage after definitive histology</td></tr><tr><td>PresumedStage on MRI</td><td>IA</td><td>IB</td><td>IC</td><td>IIA</td><td>IIB</td><td>IIIA</td><td>Total</td></tr><tr><td>IA</td><td>28.5%</td><td>43%</td><td>14.2%</td><td>0</td><td>14.2%</td><td>0</td><td>14</td></tr><tr><td>IB</td><td>... | <table><tr><td colspan="8">FIGO stage after definitive histology</td></tr><tr><td>PresumedStage on MR</td><td>I</td><td></td><td>I</td><td>IIA</td><td>II</td><td>I</td><td>Tota</td></tr></table> | <table><tr><td>I</td><td>A</td><td>IB</td><td>C</td><td></td><td>B</td><td>IIA</td><td>l</td></tr><tr><td>IA</td><td>28.5%</td><td>43%</td><td>14.2%</td><td>0</td><td>14.2%</td><td>0</td><td>14</td></tr><tr><td>IB</td><td>31.5%</td><td>40%</td><td>23%</td><td>5.5%</td><td>0</td><td>0</td><td>35</td></tr><tr><td>IC</td>... |
fa3f0112e097c434c7c283dc2feb1240cee3fa545f28d40c17903727c4fd6870.png | simple | <table><tr><td></td><td>Low ox-LDL<69.4 U/L(n = 80)</td><td>High ox-LDL≥ 69.4 U/L(n = 80)</td><td><i>P</i>-value*</td></tr><tr><td>Women (%)</td><td>60.8</td><td>52.6</td><td>0.305</td></tr><tr><td>Age (y)</td><td>23.1 ± 3.6</td><td>23.4 ± 3.4</td><td>0.145</td></tr><tr><td>BMI (kg/m<sup>2</sup>)</td... | <table><tr><td></td></tr><tr><td>Women (%)</td></tr><tr><td>Age (y)</td></tr><tr><td>BMI (kg/m2)</td></tr><tr><td>Waist circumference (cm)</td></tr><tr><td>Waist-to-hip ratio</td></tr><tr><td>Sum of 4 ST (mm)</td></tr><tr><td>Truncal fat (%)</td></tr><tr><td>Total body fat (%)</td></tr><tr><td>Body fat mass (kg)</td></... | <table><tr><td>Low ox-LDL<69.4 U/L(n = 80)</td><td>High ox-LDL≥ 69.4 U/L(n = 80)</td><td>P-value*</td></tr><tr><td>60.8</td><td>52.6</td><td>0.305</td></tr><tr><td>23.1 ± 3.6</td><td>23.4 ± 3.4</td><td>0.145</td></tr><tr><td>21.6 ± 2.8</td><td>22.4 ± 3.0</td><td>0.046</td></tr><tr><td>78.0 ± 8.7</td><td>78.3 ± 8.7</td>... |
a5762c2be249c10f0017e931f24e41a4f05bfd31f07c3f6f4e380d2edb26c1e4.png | simple | <table><tr><td>Observation</td><td>Genotype</td><td>Males</td><td>Females</td></tr><tr><td>Body weight (g)</td><td>WT</td><td>31.5 ± 18.8</td><td>20.3 ± 0.9</td></tr><tr><td></td><td>TG</td><td>25.5 ± 1.7*</td><td>22.2 ± 0.9</td></tr><tr><td>Body length (mm)</td><td>WT</td><td>92.8 ± 0.9</td><t... | <table><tr><td>Observation</td></tr><tr><td>Body weight (g)</td></tr><tr><td></td></tr><tr><td>Body length (mm)</td></tr><tr><td></td></tr><tr><td>Grip strength (score 0–4)</td></tr><tr><td></td></tr><tr><td>Wire maneuver (score 0–4)</td></tr><tr><td></td></tr><tr><td>Tail elevation (score 0–2)</td></tr><tr><td></td></... | <table><tr><td>Genotype</td><td>Males</td><td>Females</td></tr><tr><td>WT</td><td>31.5 ± 18.8</td><td>20.3 ± 0.9</td></tr><tr><td>TG</td><td>25.5 ± 1.7*</td><td>22.2 ± 0.9</td></tr><tr><td>WT</td><td>92.8 ± 0.9</td><td>86.6 ± 0.5</td></tr><tr><td>TG</td><td>89.4 ± 1.0*</td><td>87.8 ± 1.1</td></tr><tr><td>WT</td><td>2.4... |
a7f8011e15b8561a8ed31c9e55630d9b0c5ec74b6da26598154ea30ab4416d9d.png | simple | <table><tr><td></td><td>Quartile 1</td><td>Quartile 2</td><td>Quartile 3</td><td>Quartile 4</td></tr><tr><td>NBA</td><td>340.6 (357.7)</td><td>371.5 (374.9)</td><td>364.6 (369.7)</td><td>408.9 (398.6)</td></tr><tr><td>NFL</td><td>65.0 (60.2)</td><td>64.4 (59.7)</td><td>65.6 (57.7)</td><td>67.7 (63.4)</td></tr><tr><td>N... | <table><tr><td></td><td>Quartile 1</td><td>Quartile 2</td><td>Quartile 3</td><td>Quartile 4</td></tr><tr><td>NBA</td><td>340.6 (357.7)</td><td>371.5 (374.9)</td><td>364.6 (369.7)</td><td>408.9 (398.6)</td></tr><tr><td>NFL</td><td>65.0 (60.2)</td><td>64.4 (59.7)</td><td>65.6 (57.7)</td><td>67.7 (63.4)</td></tr></table> | <table><tr><td></td><td>Quartile 1</td><td>Quartile 2</td><td>Quartile 3</td><td>Quartile 4</td></tr><tr><td>NHL</td><td>313.7 (359.3)</td><td>366.6 (424.8)</td><td>394.9 (424.6)</td><td>410.9 (402.6)</td></tr></table> |
47568a00074caaca4eb5023c6c125a0577a5ed56dcd6b35d5d6b470ac7ad8ad8.png | simple | <table><tr><td></td><td>n</td><td>Age (years)</td><td>Education (years)</td><td>Frailty index</td><td>Social vulnerability index</td><td>Protection index</td><td>CASI error at baseline</td></tr><tr><td>Full cohort</td><td>3,845</td><td>77.9 (4.7)</td><td>10.5 (3.2)</td><td>0.15 (0.09)</td><td>0.25 (0.13)</td><td>0.36 (... | <table><tr><td></td><td>n</td><td>Age (years)</td><td>Education (years)</td><td>Frailty index</td><td>Social vulnerability index</td><td>Protection index</td><td>CASI error at baseline</td></tr><tr><td>Full cohort</td><td>3,845</td><td>77.9 (4.7)</td><td>10.5 (3.2)</td><td>0.15 (0.09)</td><td>0.25 (0.13)</td><td>0.36 (... | <table><tr><td></td><td>n</td><td>Age (years)</td><td>Education (years)</td><td>Frailty index</td><td>Social vulnerability index</td><td>Protection index</td><td>CASI error at baseline</td></tr><tr><td>Alive at second follow-up</td><td>2,759</td><td>76.9 (4.0)</td><td>10.7 (3.2)</td><td>0.14 (0.08)</td><td>0.24 (0.12)<... |
20c60da7a8ddf540d49208881379340cf61b240f248cc11a12516d055cafb77b.png | complex | <table><tr><td>ID</td><td>No. of seed</td><td>FA level</td><td>Oleic acid (C18:1)</td><td>Linoleic acid (C18:2)</td><td>Linolenic acid (C18:3)</td><td>Erucic acid (C22:1 )</td></tr><tr><td rowspan="3">WG4-3</td><td rowspan="3">18</td><td>Mean ± SD <sup>a</sup></td><td>20.1 ± 2.4**</td><td>2.7 ± 0.9**</td... | <table><tr><td>ID</td><td>No. of seed</td><td>FA level</td><td>Oleic acid (C18:1)</td><td>Linoleic acid (C18:2)</td><td>Linolenic acid (C18:3)</td><td>Erucic acid (C22:1 )</td></tr><tr><td rowspan="2">WG4-3</td><td rowspan="2">18</td><td>Mean ± SD a</td><td>20.1 ± 2.4**</td><td>2.7 ± 0.9**</td><td>3.0 ± 0.8**</td><td>6... | <table><tr><td rowspan="2"></td><td rowspan="2"></td><td>ax</td><td></td><td></td><td>4</td><td>69.3</td></tr><tr><td>Min</td><td>16.8</td><td>1.6</td><td>1.9</td><td>54.6</td></tr><tr><td rowspan="3">WG4-4</td><td rowspan="3">20</td><td>Mean ± SD</td><td>20.0 ± 1.1**</td><td>2.3 ± 0.5**</td><td>3.0 ± 0.5**</td><td>67 ... |
07f35eb11569c4d75a787d7db4748c576522387fe5eff5d9128b13bc0e0caeff.png | simple | <table><tr><td>Sample ID</td><td>Tumor type</td><td>Tumor cell (%)</td><td>Sequencing depth (x)</td><td>JAK2 p.V617F allele fraction (%)</td><td>Co-occurring mutation (allele fraction %)</td></tr><tr><td>592</td><td>Non-small cell carcinoma</td><td>30</td><td>1999</td><td>8.2</td><td>KRAS p.G12V (17.2)</td></tr><tr><td... | <table><tr><td>Sample ID</td><td>Tumor type</td><td>Tumor cell (%)</td><td>Sequencing depth (x)</td><td>JAK2 p.V617F allele fraction (%)</td><td>Co-occurring mutation (allele fraction %)</td></tr><tr><td></td><td>Non-small cel</td><td>30</td><td>1999</td><td>8.</td><td>KRAS p.</td></tr></table> | <table><tr><td>Sample ID</td><td>Tumor type</td><td>Tumor cell (%)</td><td>Sequencing depth (x)</td><td>JAK2 p.V617F allele fraction (%)</td><td>Co-occurring mutation (allele fraction %)</td></tr><tr><td>592</td><td>l carcinoma</td><td></td><td></td><td>2</td><td>G12V (17.2)</td></tr><tr><td>664</td><td>Adenocarcinoma ... |
cee52e430fd77f1bf4840cf3a78e3671e58bc19f65271d03fab0df53e43ff830.png | complex | <table><tr><td colspan="2">Instrument</td><td></td><td colspan="2">Before therapy (t<sub>1</sub>)</td><td colspan="2">Four weeks after therapy (t<sub>2</sub>)</td><td colspan="2">One year after therapy (t<sub>3</sub>)</td><td colspan="2">Statistics (t<sub>1 </sub>to t<sub>3</sub>)</td></tr><tr><td></td><td></td><td>N</... | <table><tr><td colspan="2">Instrument</td><td></td><td colspan="2">Before therapy (t1)</td><td colspan="2">Four weeks after therapy (t2)</td><td colspan="2">One year after therapy (t3)</td><td colspan="2">Statistics (t1 to t3)</td></tr><tr><td></td><td></td><td>N</td><td>Mean Value</td><td>SD</td><td>Mean Value</td><td... | <table><tr><td colspan="2">Instrument</td><td></td><td colspan="2">Before therapy (t1)</td><td colspan="2">Four weeks after therapy (t2)</td><td colspan="2">One year after therapy (t3)</td><td colspan="2">Statistics (t1 to t3)</td></tr><tr><td></td><td></td><td>N</td><td>Mean Value</td><td>SD</td><td>Mean Value</td><td... |
19ae047444c8677f65a60d56b61663b3e0e7630b788a93b401997da5a5247d0a.png | simple | <table><tr><td>Ligand</td><td><i>K</i><sub>d</sub> (μM)</td><td>ΔH (kcal/mol)</td><td>TΔS (kcal/mol)</td><td>n Value</td></tr><tr><td>α-KG</td><td>34.4 ± 6.63</td><td>−6.03 ± 0.56</td><td>0.06</td><td>0.80 ± 0.05</td></tr><tr><td>NOG</td><td>5.35 ± 1.26</td><td>−5.14 ... | <table><tr><td>Ligand</td><td>Kd (μM)</td></tr><tr><td>α-KG</td><td>34.4 ± 6.63</td></tr><tr><td>NOG</td><td>5.35 ± 1.26</td></tr><tr><td>Succinate</td><td>ND</td></tr><tr><td>U</td><td>ND</td></tr><tr><td>T</td><td>32.0 ± 5.24</td></tr><tr><td>5hmU</td><td>30.5 ± 5.59</td></tr><tr><td>5fU</td><td>108 ± 13.0</td></tr><... | <table><tr><td>ΔH (kcal/mol)</td><td>TΔS (kcal/mol)</td><td>n Value</td></tr><tr><td>−6.03 ± 0.56</td><td>0.06</td><td>0.80 ± 0.05</td></tr><tr><td>−5.14 ± 0.20</td><td>2.05</td><td>1.04 ± 0.03</td></tr><tr><td>ND</td><td>ND</td><td>ND</td></tr><tr><td>ND</td><td>ND</td><td>ND</td></tr><tr><td>−8.45 ± 0.74</td><td>-2.3... |
504eacfd7ee891857b5ace636d4c59f94aa393c658a0618a80bac818b8d91710.png | simple | <table><tr><td>Category</td><td>Gene</td><td>Homolog</td><td>WT1</td><td>WT2</td><td>MT</td><td>Description</td><td>Reference</td></tr><tr><td>Iron transport</td><td><i>Ftr1</i></td><td>HMPREF1120_04509</td><td>6.76</td><td>64.20</td><td>53.35</td><td>High-affinity iron transporter</td><td>Stearman et al., 1996</td></t... | <table><tr><td>Category</td><td>Gene</td><td>Homolog</td><td>WT1</td><td>WT2</td><td>MT</td><td>Description</td><td>Reference</td></tr><tr><td>Iron transport</td><td>Ftr1</td><td>HMPREF1120_04509</td><td>6.76</td><td>64.20</td><td>53.35</td><td>High-affinity iron transporter</td><td>Stearman et al., 1996</td></tr><tr><... | <table><tr><td>Category</td><td>Gene</td><td>Homolog</td><td>WT1</td><td>WT2</td><td>MT</td><td>Description</td><td>Reference</td></tr><tr><td></td><td>SidF</td><td>HMPREF1120_01438</td><td>4.55</td><td>3.58</td><td>5.95</td><td>Acetyl CoA:N6-hydroxylysine acetyl transferase</td><td>Chen et al., 2014</td></tr><tr><td><... |
7a5b1623a9dc65531889834e4732bbe0c6a46d14662084e8fea55217de5f2c9c.png | complex | <table><tr><td>Structural themes</td><td>Referential themes</td></tr><tr><td rowspan="2">To be prepared for emergency situations</td><td>Focus on overview of accident site and patient and on need of feedback</td></tr><tr><td><i>To observe the situation</i> -<i>Ready to act Confirmation</i> and <i>Validation of one̵... | <table><tr><td>Structural themes</td><td>Referential themes</td></tr><tr><td>To be</td><td>Focus on overview of accident </td></tr></table> | <table><tr><td rowspan="2"> prepared for emergency situations</td><td>site and patient and on need of feedback</td></tr><tr><td>To observe the situation -Ready to act Confirmation and Validation of one’s knowledge</td></tr><tr><td rowspan="3">Confidence in one’s own leadership</td><td>Focus on handling leadership.</td>... |
1b298a1c53cf5891bda2005dada9772673eeea7511f29d70d2a0dc1789911663.png | simple | <table><tr><td> Variable</td><td>Healthy controls (<i>n</i> = 17)</td><td>Individuals with schizophrenia (<i>n</i> = 16)</td><td><i>t </i>(df = 31)*</td><td><i>P</i> value</td></tr><tr><td>Age (years)</td><td>43.65 ± 11.32</td><td>48.69 ±8.38</td><td>−1.446</td><td>.158</td></tr><tr><td>Gender</td><td>3... | <table><tr><td>Variable</td><td>Healthy controls (n = 17)</td><td>Individuals with schizophrenia (n = 16)</td><td>t (df = 31)*</td><td>P value</td></tr><tr><td>Age (years)</td><td>43.65 ± 11.32</td><td>48.69 ±8.38</td><td>−1.446</td><td>.158</td></tr><tr><td>Gender</td><td>3 females; 14 males</td><td>4 females; 12 male... | <table><tr><td>ANSS</td><td>NA</td><td>.41</td><td>A</td><td></td></tr><tr><td>Negative scale PANSS</td><td>NA</td><td>22.33± 9.56</td><td>NA</td><td>NA</td></tr><tr><td>General psychopathology PANSS</td><td>NA</td><td>43.00 ± 14.64</td><td>NA</td><td>NA</td></tr><tr><td>Total psychopathology PANSS</td><td>NA</td><td>8... |
17ea6248dad21918ec259bfcb8b1167b14e15a11c1f6b68c4df07cd9c3e9ec50.png | simple | <table><tr><td>Flavonoid class</td><td>Molecular Weight</td><td>Glycosylation</td><td>Metabolic conversion</td><td>Colonic microflora</td></tr><tr><td>General</td><td>Decreases bioavailability</td><td>Generally removed</td><td>Major factor in bioavailability; can take place in small intestine, liver and colon; usually ... | <table><tr><td>Flavonoid class</td><td>Molecular Weight</td><td>Glycosylation</td><td>Metabolic conversion</td><td>Colonic microflora</td></tr></table> | <table><tr><td>General</td><td>Decreases bioavailability</td><td>Generally removed</td><td>Major factor in bioavailability; can take place in small intestine, liver and colon; usually to glucuronides but also sulphation and methylation [39]; facilitates urinary and biliary excretion [39].</td><td>Influence availability... |
b341a9bb1786cce467068909afd66a3c7c18f99b45a1266e170e5c7c65edc0f5.png | simple | <table><tr><td>Rabbit no.</td><td>Control collagen<sup>a </sup>(absorbance)</td><td>Loaded collagen (absorbance)</td><td>Difference</td></tr><tr><td>1</td><td>37.8</td><td>31.8</td><td>-6.0</td></tr><tr><td>2</td><td>29.8</td><td>28.2</td><td>-1.6</td></tr><tr><td>3</td><td>31.1</td><td>33.0</td><td>1.9</td></tr><tr><t... | <table><tr><td>Rabbit no.</td><td>Control collagena (absorbance)</td><td>Loaded collagen (absorbance)</td></tr><tr><td>1</td><td>37.8</td><td>31.8</td></tr><tr><td>2</td><td>29.8</td><td>28.2</td></tr><tr><td>3</td><td>31.1</td><td>33.0</td></tr><tr><td>4</td><td>42.6</td><td>38.3</td></tr><tr><td>5</td><td>31.0</td><t... | <table><tr><td>Difference</td></tr><tr><td>-6.0</td></tr><tr><td>-1.6</td></tr><tr><td>1.9</td></tr><tr><td>-4.3</td></tr><tr><td>1.1</td></tr><tr><td>-2.0</td></tr><tr><td>-1.8</td></tr><tr><td>3.0</td></tr><tr><td>>0.05</td></tr></table> |
6d8183e6aad8588bad9a799a5905ec0b81af59b88628cd9609cf8fe4c5ca9819.png | complex | <table><tr><td>#</td><td>Name</td><td colspan="3">Tag/Fusion protein, position<sup>a</sup> and length<sup>b</sup></td><td>TEV protease cleavage site</td><td>Mode of expression</td><td>EAEA repeat</td><td>Selection marker<sup>c</sup></td><td>Plasmid size (bp)</td></tr><tr><td>1</td><td>PPpRSFC</td><td>–</td><td>&#... | <table><tr><td>#</td><td>Name</td><td colspan="3">Tag/Fusion protein, positiona and lengthb</td><td>TEV protease cleavage site</td><td>Mode of expression</td><td>EAEA repeat</td><td>Selection markerc</td><td>Plasmid size (bp)</td></tr><tr><td>1</td><td>PPpRSFC</td><td>–</td><td>–</td><td>–</td><td>NA</td><td>Intracellu... | <table><tr><td>#</td><td>Name</td><td colspan="3">Tag/Fusion protein, positiona and lengthb</td><td>TEV protease cleavage site</td><td>Mode of expression</td><td>EAEA repeat</td><td>Selection markerc</td><td>Plasmid size (bp)</td></tr><tr><td>8</td><td></td><td></td><td>–</td><td></td><td>A</td><td>lar</td><td></td><td... |
9e2aceaf9ac0d394349e390bd93e4479d7b3c23ca13f31ecccd7d51a29fa6768.png | simple | <table><tr><td>Characteristic</td><td>Value</td></tr><tr><td>Total number</td><td>35</td></tr><tr><td>Median age (IQR) in months</td><td>20 (16–22)</td></tr><tr><td>Females (%)</td><td>19 (54%)</td></tr><tr><td>Median children in household (range)</td><td>3 (1–6)</td></tr><tr><td>Smokers in household (%)</t... | <table><tr><td>Characteristic</td><td>Value</td></tr><tr><td>Total number</td><td>35</td></tr><tr><td>Median age (IQR) in months</td><td>20 (16–22)</td></tr><tr><td>Females (%)</td><td>19 (54%)</td></tr><tr><td>Median children in household (range)</td><td>3 (1–6)</td></tr></table> | <table><tr><td>Smokers in household (%)</td><td>11 (31%)</td></tr><tr><td>Received 3 doses of pentavalent vaccine</td><td>91.4%</td></tr><tr><td>Received at least 1 dose of pentavalent vaccine</td><td>100.0%</td></tr></table> |
e0021b12d885955cfcfd8ad03c7b83ab7be28aeecb3eed175fe58c9fc5d367da.png | simple | <table><tr><td>#</td><td>Assumption</td></tr><tr><td>1</td><td>There is active secretion of compounds from blood to the lumen of the kidney's proximal tubules and reverse reabsorption (Liu et al., 2012)</td></tr><tr><td>2</td><td>Only an unbound drug could be filtrated or secreted from plasma to the lumen of the kidney... | <table><tr><td>#</td><td>Assumption</td></tr><tr><td>1</td><td>There is active secretion of compounds from blood to the lumen of the kidney's proximal tubules and reverse reabsorption (Liu et al., 2012)</td></tr><tr><td>2</td><td>Only an unbound drug could be filtrated or secreted from plasma to the lumen of the kidney... | <table><tr><td>6</td><td>et al., 2012)</td></tr><tr><td>7</td><td>All rate equations are to be described as mass action law</td></tr></table> |
b7bc978bd8072bbe84caecb47ce159a43bfec0e1bb1ad6a775b5785b64b495f3.png | complex | <table><tr><td rowspan="2"></td><td colspan="3"><i>MOCOS</i></td></tr><tr><td colspan="3"><i>c.1881delG /c.1782delG</i></td></tr><tr><td></td><td>G/G</td><td>G/del</td><td>del/del</td></tr><tr><td>Affected animals</td><td></td><td></td><td>4</td></tr><tr><td>Obligate carriers</td><td></td><td>3</td><td></td></tr><tr><t... | <table><tr><td rowspan="2"></td><td colspan="3">MOCOS</td></tr><tr><td colspan="3">c.1881delG /c.1782delG</td></tr><tr><td></td><td>G/G</td><td>G/del</td><td>del/del</td></tr><tr><td>Affected animals</td><td></td><td></td><td>4</td></tr></table> | <table><tr><td rowspan="2"></td><td colspan="3">MOCOS</td></tr><tr><td colspan="3">c.1881delG /c.1782delG</td></tr><tr><td></td><td>G/G</td><td>G/del</td><td>del/del</td></tr><tr><td>Obligate carriers</td><td></td><td>3</td><td></td></tr><tr><td>Tyrolean Grey population controls</td><td>1151</td><td>50</td><td></td></t... |
23bcdc7bfcd53f98f96728a7381abe4cf1e072e63024237ddb2baba4f8703c93.png | simple | <table><tr><td>Health Claims (Dedicated Children’s Channels)</td><td>2010 (%)</td><td>% Change v 2008 (+/−)</td><td>2010 All Channels (%)</td></tr><tr><td>Contains essential nutrients e.g., calcium, vitamins, antioxidants</td><td>39.7</td><td>+29</td><td>33.4</td></tr><tr><td>Part of your five a day</td><td... | <table><tr><td>Health Claims (Dedicated Children’s Channels)</td><td>2010 (%)</td><td>% Change v 2008 (+/−)</td><td>2010 All Channels (%)</td></tr><tr><td>Contains essential nutrients e.g., calcium, vitamins, antioxidants</td><td>39.7</td><td>+29</td><td>33.4</td></tr><tr><td>Part of your five a day</td><td>28.9</td><t... | <table><tr><td>Health Claims (Dedicated Children’s Channels)</td><td>2010 (%)</td><td>% Change v 2008 (+/−)</td><td>2010 All Channels (%)</td></tr><tr><td>Contains fibre</td><td>0.6</td><td>+0.6</td><td>1.3</td></tr><tr><td>Is low calorie/light</td><td>0.6</td><td>−5.1</td><td>5.1</td></tr></table> |
db3eed840fea40688951d40de87e352ef026d198175a8ecb758724759e90ebba.png | complex | <table><tr><td rowspan="2">Configuration</td><td colspan="4">Packets Received per Second</td></tr><tr><td>CSR1</td><td>CSR2</td><td>CSR3</td><td>Average</td></tr><tr><td>CSR devices transmit each packet one</td><td>0.62</td><td>1.41</td><td>1.08</td><td>1.04</td></tr><tr><td>CSR devices transmit each packet three times... | <table><tr><td rowspan="2">Configuration</td><td colspan="3">Packets Received per Second</td></tr><tr><td>CSR1</td><td>CSR2</td><td>CSR3</td></tr><tr><td>CSR devices transmit each packet one</td><td>0.62</td><td>1.41</td><td>1.08</td></tr><tr><td>CSR devices transmit each packet three times</td><td>1.16</td><td>1.76</t... | <table><tr><td>Packets Received per Second</td></tr><tr><td>Average</td></tr><tr><td>1.04</td></tr><tr><td>1.61</td></tr></table> |
b1992d3394b7fed685b05d5c8b314ad89779656a845734333a1b9cad4e1dcd24.png | simple | <table><tr><td>Variables</td><td>Control subjects (n = 62)</td><td>Type 1 diabetes (n = 53)</td><td>Ketosis-onset diabetes (n = 208)</td><td>Non-ketotic type 2 diabetes (n = 215)</td><td><i>p </i>values</td><td>*<i>p </i>values</td></tr><tr><td>Male (%)</td><td>43 (69.4%)</td><td>31 (58.5%)</td><td>153 (73.6%)</td><td>... | <table><tr><td>Variables</td><td>Control subjects (n = 62)</td><td>Type 1 diabetes (n = 53)</td><td>Ketosis-onset diabetes (n = 208)</td><td>Non-ketotic type 2 diabetes (n = 215)</td><td>p values</td><td>*p values</td></tr><tr><td>Male (%)</td><td>43 (69.4%)</td><td>31 (58.5%)</td><td>153 (73.6%)</td><td>122 (56.7%)</t... | <table><tr><td>Variables</td><td>Control subjects (n = 62)</td><td>Type 1 diabetes (n = 53)</td><td>Ketosis-onset diabetes (n = 208)</td><td>Non-ketotic type 2 diabetes (n = 215)</td><td>p values</td><td>*p values</td></tr><tr><td>TC (mmol/l)</td><td>4.84 ± 1.02</td><td>4.83 ± 1.09</td><td>5.03 ± 1.22</td><td>4.82 ± 1.... |
d089d46e0aac4744d68e51c71864971469cd32202b6095b9d4ab71ba3a002df7.png | simple | <table><tr><td>Surface</td><td>Contact angle (deg.)</td><td>Contact angle hysteresis (deg.)</td><td>Sliding angle (deg.)</td></tr><tr><td>TO-SHS</td><td>169±4</td><td>45±15</td><td>>45</td></tr><tr><td>TO-SLIPS</td><td>124±1</td><td>1.4±0.5</td><td>3.0±0.3</td></tr></table> | <table><tr><td>Surface</td><td>Contact angle (deg.)</td><td>Contact angle hysteresis (deg.)</td><td>Sliding angle (deg.)</td></tr><tr><td>TO-SHS</td><td>169±4</td><td>45±15</td><td>>45</td></tr></table> | <table><tr><td>Surface</td><td>Contact angle (deg.)</td><td>Contact angle hysteresis (deg.)</td><td>Sliding angle (deg.)</td></tr><tr><td>TO-SLIPS</td><td>124±1</td><td>1.4±0.5</td><td>3.0±0.3</td></tr></table> |
0b470a9a3f4e1dc2b15dcbaeafb83566d7f7087fe12d1b4841b1a1359acbea4b.png | simple | <table><tr><td>Dose (mg kg<sup>−1</sup>) </td><td>Fatty change</td><td>Hydropic swelling</td><td>Mild inflammation</td><td>Mild fibrosis</td></tr><tr><td>Saline</td><td>0/4</td><td>0/4</td><td>0/4</td><td>0/4</td></tr><tr><td>30</td><td>0/4</td><td>0/4</td><td>0/4</td><td>0/4</td></tr><tr><td>100</td><td>0/4</td>... | <table><tr><td>Dose (mg kg−1)</td><td>Fatty change</td><td>Hydropic swelling</td><td>Mild inflammation</td><td>Mild fibrosis</td></tr><tr><td>Saline</td><td>0/4</td><td>0/4</td><td>0/4</td><td>0/4</td></tr></table> | <table><tr><td>30</td><td>0/4</td><td>0/4</td><td>0/4</td><td>0/4</td></tr><tr><td>100</td><td>0/4</td><td>0/4</td><td>4/4</td><td>0/4</td></tr><tr><td>300</td><td>0/4</td><td>1/4</td><td>4/4</td><td>0/4</td></tr><tr><td>1000</td><td>2/4</td><td>4/4</td><td>4/4</td><td>0/4</td></tr><tr><td>3000</td><td>2/4</td><td>4/4<... |
bc1d089cb5a6423693ff6ef478ae2284be704851b8791ebb38a3b7fba677614a.png | simple | <table><tr><td>Sample</td><td><i>a</i> (m<sup>2</sup>·kW<sup>−1</sup>·s<sup>−1/2</sup>)</td><td><i>b</i> (s<sup>−1/2</sup>)</td><td><i>R</i><sup>2</sup></td></tr><tr><td>NC-F, 1 g</td><td>0.03537</td><td>−0.1046</td><td>0.9459</td></tr><tr><td>NC-F, 2 g</td><td>0.03117</td><td>0.23889<... | <table><tr><td>Sample</td><td>a (m2·kW−1·s−1/2)</td><td>b (s−1/2)</td><td>R2</td></tr><tr><td>NC-F, 1 g</td><td>0.03537</td><td>−0.1046</td><td>0.9459</td></tr><tr><td>NC-F, 2 g</td><td>0.03117</td><td>0.23889</td><td>0.30557</td></tr><tr><td>NC-C; 1 g</td><td>0.01161</td><td>−0.01993</td><td>0.99933</td></tr></table> | <table><tr><td>NC-C; 2 g</td><td>0.011</td><td>−0.00607</td><td>0.99423</td></tr></table> |
1c27e2bd73692e4e9c26b510bf1f27b2d8d5e06707b7e6632c56c00696f972cb.png | simple | <table><tr><td></td><td>OR<sup>a</sup> (95% CI)</td><td><i>p</i>-Value</td></tr><tr><td>Cannabis<sup>b</sup></td><td></td><td></td></tr><tr><td>Use at 1 time-point</td><td>1.32 (0.94–1.86)</td><td>0.112</td></tr><tr><td>Use at 2 time-points</td><td>1.71 (1.08–2.70)</td><td>0.023</td></tr><tr><td>Use at 3 ti... | <table><tr><td></td><td>ORa (95% CI)</td><td>p-Value</td></tr><tr><td>Cannabisb</td><td></td><td></td></tr></table> | <table><tr><td></td><td>ORa (95% CI)</td><td>p-Value</td></tr><tr><td>Use at 1 time-point</td><td>1.32 (0.94–1.86)</td><td>0.112</td></tr><tr><td>Use at 2 time-points</td><td>1.71 (1.08–2.70)</td><td>0.023</td></tr><tr><td>Use at 3 time-points</td><td>2.08 (1.16–3.74)</td><td>0.025</td></tr><tr><td>Use at 4 time-points... |
f6d43e09845c6d149db61ad98306c11227148106c54f0234c1b9065fb634d4ad.png | complex | <table><tr><td></td><td></td><td colspan="2"><i>n</i>, mean (SD)</td><td colspan="2">GLM analysis</td></tr><tr><td>Subgroup variable</td><td>Category</td><td>PTA</td><td>TAU</td><td>Difference and 95%CI</td><td><i>p</i>-value</td></tr><tr><td>Age at screening (year)</td><td></td><td></td><td></td><td></td><td></td></tr... | <table><tr><td></td><td></td><td colspan="2">n, mean (SD)</td><td colspan="2">GLM analysis</td></tr><tr><td>Subgroup variable</td><td>Category</td><td>PTA</td><td>TAU</td><td>Difference and 95%CI</td><td>p-value</td></tr><tr><td>Age at screening (year)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td></td>... | <table><tr><td></td><td></td><td colspan="2">n, mean (SD)</td><td colspan="2">GLM analysis</td></tr><tr><td>Subgroup variable</td><td>Category</td><td>PTA</td><td>TAU</td><td>Difference and 95%CI</td><td>p-value</td></tr><tr><td></td><td></td><td>.64)</td><td>9,5.94 (1.45)</td><td>,0.60)</td><td>92</td></tr><tr><td></t... |
22e8a575b6dcddbb52fdd319806f9cb517409ef80b0a3ab8a6e117d2cb0a1f23.png | simple | <table><tr><td></td><td>p3-m2</td><td>p3-m1</td><td>p3-p4</td><td>p3 L</td><td>p3 W</td><td>p4 L</td><td>p4 Wtr</td><td>p4 Wtal</td><td>P3 L</td><td>P3W</td></tr><tr><td>Type Sh 434</td><td>6.3</td><td>4.8</td><td>3. 15</td><td>1</td><td>1.35</td><td>1.5</td><td>1.5</td><td>1.35</td><td></td><td></td></tr><tr><td>MPC/L... | <table><tr><td></td><td>p3-m2</td><td>p3-m1</td><td>p3-p4</td><td>p3 L</td><td>p3 W</td><td>p4 L</td><td>p4 Wtr</td><td>p4 Wtal</td><td>P3 L</td><td>P3W</td></tr><tr><td>Type Sh 434</td><td>6.3</td><td>4.8</td><td>3. 15</td><td>1</td><td>1.35</td><td>1.5</td><td>1.5</td><td>1.35</td><td></td><td></td></tr></table> | <table><tr><td></td><td>p3-m2</td><td>p3-m1</td><td>p3-p4</td><td>p3 L</td><td>p3 W</td><td>p4 L</td><td>p4 Wtr</td><td>p4 Wtal</td><td>P3 L</td><td>P3W</td></tr><tr><td>MPC/L-0001 (LUS-29)</td><td>4.75</td><td>3.35</td><td>2</td><td>0.8</td><td>1</td><td>1.35</td><td>1.25</td><td>1.15</td><td></td><td></td></tr><tr><t... |
0fde81c23a286f90cf7f9f598104287443766e82f7adaeaffd164ae157102336.png | complex | <table><tr><td>Life Satisfaction<sup>a</sup></td><td>2005</td><td>2007</td><td>2009</td><td>2011</td><td>2013</td></tr><tr><td colspan="6">Health</td></tr><tr><td> 1</td><td>781 (22.2)</td><td>535 ((17.6)</td><td>461 (17.4)</td><td>207 (8.93)</td><td>130 (6.6)</td></tr><tr><td> 2</td><td>1455 (41.4)</td><td>1365 (44.8)... | <table><tr><td>Life Satisfactiona</td><td>2005</td><td>2007</td><td>2009</td><td>2011</td><td>2013</td></tr><tr><td colspan="6">Health</td></tr><tr><td>1</td><td>781 (22.2)</td><td>535 ((17.6)</td><td>461 (17.4)</td><td>207 (8.93)</td><td>130 (6.6)</td></tr><tr><td>2</td><td>1455 (41.4)</td><td>1365 (44.8)</td><td>935 ... | <table><tr><td>Life Satisfactiona</td><td>2005</td><td>2007</td><td>2009</td><td>2011</td><td>2013</td></tr><tr><td>2</td><td>1335 (38.0)</td><td>1145 (37.6)</td><td>949 (35.8)</td><td>718 (30.9)</td><td>530 (27.1)</td></tr><tr><td>3</td><td>1153 (32.8)</td><td>1072 (35.2)</td><td>957 (36.1)</td><td>962 (41.4)</td><td>... |
9474928101c79398e63c8932c67e597bf8d53db20ca0fdf1408cfdc7e0dcadb1.png | simple | <table><tr><td>Pool</td><td>DMRs (Number)</td><td>DMRs (%)</td></tr><tr><td>Bulgarian females (patients/controls)</td><td>293</td><td>1.1</td></tr><tr><td>Bulgarian males (patients/controls)</td><td>948</td><td>3.4</td></tr><tr><td>Serbian females (patients/controls)</td><td>947</td><td>3.4</td></tr><tr><td>Serbian mal... | <table><tr><td></td><td>DMR</td><td>DMR</td></tr></table> | <table><tr><td>Pool</td><td>s (Number)</td><td>s (%)</td></tr><tr><td>Bulgarian females (patients/controls)</td><td>293</td><td>1.1</td></tr><tr><td>Bulgarian males (patients/controls)</td><td>948</td><td>3.4</td></tr><tr><td>Serbian females (patients/controls)</td><td>947</td><td>3.4</td></tr><tr><td>Serbian males (pa... |
ad1ccd9ae5c7160b8f874d5b8a48a9d796a3e62b2fb064302f3090cde23bb5d6.png | complex | <table><tr><td>Time</td><td>AUC</td><td>CRI</td><td>Predicting</td><td>Sensitivity (CI)</td><td>Specificity (CI)</td><td>PPV (CI)</td><td>NPV (CI)</td></tr><tr><td colspan="8">A. Training set</td></tr><tr><td>12 h</td><td>0.83</td><td><0.04</td><td>Poor outcome</td><td>0.27 (0.11–0.50)</td><td>1.00 (0.86–... | <table><tr><td>Time</td><td>AUC</td><td>CRI</td><td>Predicting</td><td>Sensitivity (CI)</td><td>Specificity (CI)</td><td>PPV (CI)</td><td>NPV (CI)</td></tr><tr><td colspan="8">A. Training set</td></tr><tr><td>12 h</td><td>0.83</td><td><0.04</td><td>Poor outcome</td><td>0.27 (0.11–0.50)</td><td>1.00 (0.86–1.00)</td><td>... | <table><tr><td></td><td></td><td>>1.00</td><td>Good outcome</td><td>0.00 (0.00–0.14)</td><td>1.00 (0.83–1.00)</td><td>-</td><td>0.45 (0.30–0.61)</td></tr></table> |
74b34a444770511fea7b730b5b004cab3452b1f768921bd5ba2479d7605efb23.png | simple | <table><tr><td>Author</td><td>Patient (<i>n</i>) (age/sex)</td><td>Procedure</td><td>Cardiac rhythm</td><td>Cause</td><td>Management</td><td>Outcome</td></tr><tr><td>Chowdhury and West [3]</td><td>50 y ♀</td><td>Awake craniotomy (frontal tumor)</td><td>Bradycardia, asystole (25 s)</td><td>TCR (scalp traction)</td... | <table><tr><td>Author</td><td>Patient (n) (age/sex)</td><td>Procedure</td><td>Cardiac rhythm</td><td>Cause</td><td>Management</td><td>Outcome</td></tr></table> | <table><tr><td>Chowdhury and West [3]</td><td>50 y ♀</td><td>Awake craniotomy (frontal tumor)</td><td>Bradycardia, asystole (25 s)</td><td>TCR (scalp traction)</td><td>Release scalp traction; cessation propofol and remifentanil infusions</td><td>No neurological deficit</td></tr><tr><td>Prabhu et al. [4]</td><td>65 y ♂<... |
3c3157e3a15317ad54dbe04bf894cec6f1db455924743925090bb1b8fa1b635d.png | complex | <table><tr><td>Method</td><td>Rank</td><td>Rank</td><td>TPR in top</td><td>TPR in top</td><td>TPR in top</td><td>TPR in top</td><td>AUC</td><td>Rank difference</td></tr><tr><td></td><td>median</td><td>average</td><td>1% (%)</td><td>5% (%)</td><td>10% (%)</td><td>30% (%)</td><td></td><td><i>p</i>-value</td></tr><tr><td ... | <table><tr><td>Method</td><td>Rank</td><td>Rank</td><td>TPR in top</td><td>TPR in top</td><td>TPR in top</td><td>TPR in top</td><td>AUC</td><td>Rank difference</td></tr><tr><td></td><td>median</td><td>average</td><td>1% (%)</td><td>5% (%)</td><td>10% (%)</td><td>30% (%)</td><td></td><td>p-value</td></tr><tr><td colspan... | <table><tr><td>Method</td><td>Rank</td><td>Rank</td><td>TPR in top</td><td>TPR in top</td><td>TPR in top</td><td>TPR in top</td><td>AUC</td><td>Rank difference</td></tr><tr><td></td><td>median</td><td>average</td><td>1% (%)</td><td>5% (%)</td><td>10% (%)</td><td>30% (%)</td><td></td><td>p-value</td></tr><tr><td>ProDiGe... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.